WO1992022263A2 - Nitinol stent system for hollow body conduits - Google Patents

Nitinol stent system for hollow body conduits Download PDF

Info

Publication number
WO1992022263A2
WO1992022263A2 PCT/US1992/004899 US9204899W WO9222263A2 WO 1992022263 A2 WO1992022263 A2 WO 1992022263A2 US 9204899 W US9204899 W US 9204899W WO 9222263 A2 WO9222263 A2 WO 9222263A2
Authority
WO
WIPO (PCT)
Prior art keywords
wire
lumen
catheter
stent
tubular
Prior art date
Application number
PCT/US1992/004899
Other languages
French (fr)
Other versions
WO1992022263A3 (en
Inventor
Thomas O. Mcnamara
Gregory Mednick
Original Assignee
Mcnamara Thomas O
Gregory Mednick
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mcnamara Thomas O, Gregory Mednick filed Critical Mcnamara Thomas O
Priority to DE69222305T priority Critical patent/DE69222305T2/en
Priority to EP92914225A priority patent/EP0588959B1/en
Publication of WO1992022263A2 publication Critical patent/WO1992022263A2/en
Publication of WO1992022263A3 publication Critical patent/WO1992022263A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95Instruments specially adapted for placement or removal of stents or stent-grafts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/88Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure the wire-like elements formed as helical or spiral coils
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95Instruments specially adapted for placement or removal of stents or stent-grafts
    • A61F2002/9505Instruments specially adapted for placement or removal of stents or stent-grafts having retaining means other than an outer sleeve, e.g. male-female connector between stent and instrument
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95Instruments specially adapted for placement or removal of stents or stent-grafts
    • A61F2002/9505Instruments specially adapted for placement or removal of stents or stent-grafts having retaining means other than an outer sleeve, e.g. male-female connector between stent and instrument
    • A61F2002/9511Instruments specially adapted for placement or removal of stents or stent-grafts having retaining means other than an outer sleeve, e.g. male-female connector between stent and instrument the retaining means being filaments or wires
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2210/00Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2210/0014Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof using shape memory or superelastic materials, e.g. nitinol
    • A61F2210/0019Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof using shape memory or superelastic materials, e.g. nitinol operated at only one temperature whilst inside or touching the human body, e.g. constrained in a non-operative shape during surgery, another temperature only occurring before the operation

Definitions

  • the present invention relates to an improved nitinol spiral stent for use as an endoprosthesis for reinforcing these body conduits so as to maintain their patency and function.
  • the invention has been demonstrated to have particular utility for repairing narrowed, weakened, distorted, distended or otherwise deformed tubular body conduits, such as those in the vascular, biliary, genitourinary, gastrointestinal and respiratory systems.
  • the invention includes an improved delivery system for placement of the stent.
  • Previous devices for performing this function have not been designed for easy, controlled placement. Because the prior art stents were not designed to cooperate with specific placement devices and the placement devices were not designed to restrain the stent until properly located, correct placement was difficult to control. Also, prior nitinol stent systems required injection of cold saline, hot saline or both to prevent, control or encourage the transformation of the stent to its pre-set coil shape. This complicated the procedure and subjected the patient's body to unnecessary stress caused by the injection of the hot and cold fluids.
  • Shape-memory alloys have the unusual property of mechanical "memory.” These materials can be formed into a first predetermined shape above a transition temperature range (TTR) , the TTR being dependent on the particular ratio of metals in the alloy. Below the TTR the alloy is highly ductile and may be plastically deformed into a second desired shape. Upon reheating above the TTR th alloy returns to its first pre-set form.
  • TTR transition temperature range
  • the Simon device uses a nitinol material with a TTR o 40°-50°F.
  • the alloy which can be formed into various mesh o filter designs, is reformed into a straight wire in ice-coole water.
  • a stud attached to the rear of the straightened filte wire is engaged in a notch on the guide wire which is the placed in the bore of a Teflon catheter for implantation.
  • Under fluoroscopic control the catheter is advanced to th desired placement location within the blood vessel, and th guide wire and free end of the nitinol wire are extruded fro the catheter.
  • the straightened nitinol wire As the straightened nitinol wire become exposed to the temperature of the blood, it reforms into it pre-set filter shape locking it into the blood vessel and, a the notch on the guide wire with inserted stud on th straightened wire are extruded from the placement catheter, the wire automatically becomes disengaged from the placemen device.
  • U.S. Patent 3,827,426 Other medical applications of shape-memory alloys i medicine are a prosthetic pump (U.S. Patent 3,827,426), a apparatus for percutaneous catheterization (U.S.Patent 4,411,655), an intrauterine contraceptive device (U.S. Patent 3,620,212), a ring to hold a sewing cuff to an artificial heart valve (U.S. Patent 4,233,690), a catheter or cannula (U.S. Patent 3,890,977), marrow nails (U.S. Patent 4,170,990), and dental arch wires (U.S. Patent 4,037,324).
  • U.S. Patent 4,665,906 addresses the use of stress-induced martensite alloys for the formation of several different medical devices.
  • the Dotter article discloses the use of a nitinol material having a transition temperature of 130°-140°F, thus, requiring an injection of hot saline to cause the material to reform to its coil shape.
  • the Dotter patent claims a nitinol material with a transition temperature in a range at or above normal body temperature. Because the Dotter patent does not incorporate any means to restrain the coil during insertion, the placement procedure requires an initial injection of cold saline to insure the coil does not reform during insertion followed by a second injection of hot saline to encourage reformation.
  • Cragg utilizes a threaded adapter on one end of the coil to hold it during placement.
  • Alfidi discloses an appliance expansible by the application of electrical heating.
  • Balko discloses a nitinol wire with a transition temperature below body temperature. In order t prevent the stent from changing shape while being positione in the body it is enclosed in an insulating sheath.
  • the present invention is directed to a coil stent constructed from nitinol alloy, the stent having the ends thereof designed to interact with a placement device specifically fabricated to retain the stent in a second smaller diameter while the stent is manipulated to its desired position in the patient's body. Additionally, it is directed to a placement device designed to utilize the structure on the ends of the stent to restrain the stent from reformation until in its desired location.
  • Figure 1 is a side view of the coil stent in its first or expanded form according to the present invention.
  • Figure 2 is a vertical cross-sectional perspective view of the stent of Figure 1 taken along line 2-2 of Figure 1.
  • Figure 3 is a cut away view of the delivery catheter and wire guide according to the present invention.
  • Figure 4 is a cut away view of a variation of the catheter of Figure 3.
  • Figure 5 is a partial cut away view of the stent of Figure 1 in its second or delivery shape positioned in the delivery catheter of Figure 3.
  • Figure 6 is a partial cut away view of the stent o Figure 1 in its second or delivery shape positioned in th delivery catheter of Figure 4.
  • Figure 7 is an enlarged view of a portion of the cathete and stent of Figure 6.
  • Figure 8 is an enlarged cross-sectional view taken alon line 8-8 of Figure 5.
  • Figure 9 is a partial sectional view of an arter following angioplasty showing the delivery system of Figure with the stent in the process of reforming to its hig temperature configuration.
  • Roentgeno-endoprosthetic placement involves th implantation into vessels and organs of a radiopaqu prosthesis of metal alloy having a shape memory effect. Th placement procedure is performed non-surgically by a interventional radiologist using modern imaging technique which obviate the need to surgically expose the area to b treated.
  • the technique takes advantage of the shape memor behavior of nitinol.
  • a spiral o nitinol wire can be straightened into a linear configuratio or twisted into a desired shape to fit the profile of th placement device upon which the nitinol wire will be carrie to the body site to be treated.
  • the wire When heated to a temperatur above the alloy TTR, the wire re-acquires its initial shap forming a frame within the body conduit being treated.
  • the nitinol prosthesis of the invention has the followin characteristics: 1. Biological compatibility. 2. Resistance to corrosion.
  • the stent 10 is composed of a coil 12 constructed from a nickel/titanium metal alloy (nitinol) wire 14 preferably of 55% nickel and 45% titanium.
  • the wire 14 which is formed at a temperature above the TTR of the alloy into its first shape or configuration 16 can be reformed into a second configuration 18 when cooled below the TTR of the alloy.
  • the wire 14 can be returned to its first configuration 16 by exposure to a specified higher temperature above the alloy TTR.
  • Figure 1 shows the stent 10 comprising a spiral of nitinol wire 14 in its first coiled configuration 16. Loops or hooks 20 as shown in Figures 1, 5, 6 and 8 are formed in the proximal and distal ends 22 and 24 to hold the wire 14 in place after placement on the delivery catheter 30.
  • the endoprosthesis can also incorporate a silicone o other suitable biocompatible coating.
  • This coating reduce the chance of thrombosis in treated blood vessels or adherenc of food, bile, and genito-urinary deposits on the coil whic would impair the function of the vessels or tubular structur when implanted therein. If undesired depositions occur, partial or complete blockage of the treated vessel or tubula system can result, leading to jeopardy to life and limb.
  • Th coating must be chosen for the body system into which th stent will be placed. For example, coatings suitable fo placement in arterial or venous blood vessels may not b suitable for genito-urethral tracts or the respiratory system.
  • Appropriate coatings include, but are not limited to, silicon rubbers, hydrophilic polymers, biological coatings, such a heparin or other polysaccharides, collagen and other relate materials which are known to retard deposition of undesirabl materials, encourage desired tissue ingrowth or stimulate th deposition of preferential biological constituents.
  • a new and novel delivery system 30 for inserting the coil 12 which uses retention means such as fixing loops or hooks 20 at each end of the coil 10.
  • This delivery system 30 includes a tubular placement device, such as a catheter 32, which has proximal and distal cut-outs or holes 34 and 36 in its outer surface 38, allowing the loops or hooks 20 to be inserted through the wall 40 of the catheter 32 and into the bore or lumen 42 of the catheter 32 where they can be traversed or pierced by a central mandril or guide wire 44 placed within the bore of the catheter 32 as shown in Figure 5.
  • the preferred design utilizes a catheter with an opening 35 in its proximal end so that the guide wire 44 can extend out of the " catheter and through a constriction which will receive the stent. Placement of the mandril 44 through the loops 20 on the proximal and distal ends 22 and 24 of the coil 12 holds the wire 14 in its second configuration 18 so that it cannot reform to its first configuration 16 or be dislodged until the mandril 44 is withdrawn, thus ensuring proper positioning of the stent 10 in its desired final location.
  • second configuration 18 cold temperature shape
  • Figures 4 and 6 show a modification of the delivery system 30 which incorporates a depressed region 46 in and fully encircling the outer surface 38 of the catheter 32.
  • the purpose of the depressed region 46 is to allow the wire 14 t be wrapped around the catheter 32 while still retaining th uniform outer profile of the catheter 32.
  • the wire increases the diameter of the system.
  • Th depressed region 46 as shown in Figures 6 and 7, allows th wire 14 to be wrapped on the catheter 32 without increasin the outer diameter of the system, thus, making it easier t insert the system into the desired body organ.
  • the procedure for placing the stent 10, using th delivery system 30 of the present invention, within a bloo vessel, for example, an artery following an angioplast procedure is as follows: 1.
  • a wire 14 formed from a nitinol alloy with a TTR a or below body temperature is heated above its TTR to temperature necessary to form a first configuration, i.e., coil as shown in Figure 1.
  • a suitable form is a closel spaced coil, preferably with the coil turns touching eac other, having an outer diameter slightly greater than th inner diameter of the vessel into which it will be placed.
  • loop or hook 20 is formed on each end of the wire. This ca be accomplished in the hospital facility if suitable heatin and forming equipment is available.
  • the sten is supplied by the manufacturer in a range of pre-set oute diameters so that the interventional radiologist can selec the dimensions most suited to the patient's needs.
  • the formed coil is then cooled below the TTR of th alloy so that it can be reshaped into a desired secon configuration.
  • the wire is spirally wound tightly around the oute surface 38 of the depressed region 46 of the catheter 32, th loop 20 on the proximal end 22 of the wire 14 is inserted through proximal cut-out 34, and the mandril tip 45 is advanced through the loop 20 into the proximal end of the catheter 32. 5.
  • the delivery system 30 with the wire 14 in its second configuration 18 is then introduced into the body, using readily available catheter introduction system, and advanced to the site for stent 10 placement under fluoroscopic or other nonsurgical visualization procedures. 6.
  • the distal end 24 of the wire 14 is located at the distal end of the chosen delivery site the mandril 44 is partially withdrawn, freeing the proximal end 22 of the wire 14.
  • the wire 14 Having been exposed to body temperature, which is above the TTR of the alloy, the wire 14 will immediately reform into its first configuration 16 (a coil of outer diameter greater than the vessel in which it is placed) .
  • the mandril 44 can be withdrawn from the loop 20 on the distal end 24 of the wire 14. If the stent 10 is not properly positioned, it can be moved and repositioned before the mandril 44 is withdrawn from the distal loop.
  • the hook and loop 20 can be formed on the ends of the wire while it is in its second low temperature configuration.
  • the stent can be positioned in various tubular or hollow body conduits or organs.
  • the delivery system 30 for the improved nitinol stents 10 takes advantage of the fixing loops 20 at both ends of the coil 12. Specifically, this delivery system 30 comprises both a catheter 32 and guide wire 14, with the overall system having a significantly smaller diameter than the prior ar delivery systems.
  • the catheter 32 of the improved deliver system 30 has at least two cut-outs 34 and 36 in its oute surface 38 enabling the loops (or hooks) 20 to be place through the wall 40 of the catheter 32 and then traversed b a central guide wire 44 placed within the catheter 32.
  • Additional beneficial features of the delivery system ar reduction of friction and an increase in flexibility an steerability.
  • the coating on the product, while reducin deposits on the system, also reduces friction as the system is manipulated to its desired location.
  • the smaller diameter of the catheter and the commensurate flexibility, in combination with standard catheter steering techniques, allows the interventional radiologist to readily manipulate the catheter through stenotic (narrow) passages and to bend the catheter to direct the endoprosthesis to its desired location, thus, allowing access to regions that are difficult to access due to the tortuous course between the sites of introduction and implantation.
  • an angioplasty balloon can be combined with the nitinol endoprosthesis.
  • this improvement incorporates an angioplasty balloon on a catheter having two or more inner channels. One channel is for inflating the angioplasty balloon and a second channel is for insertion of the wire guide to catch the terminal loops of the nitinol stent. Contrast media or other liquids can be injected through a third channel or through the channel used for the wire guide.
  • the combined system allows the interventional radiologist to perform balloon dilatation of a hollow body conduit and place the nitinol stent in a single, controlled nonsurgical procedure with one instrument through a single access site. This ensures greatly enhanced effectiveness and safety of the balloon dilatation procedure and proper positioning prior to the release of the stent, all in rapid succession.
  • a metal guide was introduced beyond the stricture area using a previously placed external drainage catheter.
  • the forward loop was then released by slightly withdrawing the guide wire. Under body temperature, the prosthesis reformed to its pre-set spiral shape with a predetermined diameter slightly larger than the biliary tract. 6. Once the prosthesis was accurately fixed in the stricture, the second loop was released and the guide wire wa removed.
  • a 37-year old male was admitted to the hospital with symptoms of jaundice, weakness, pruritus and nausea. He had a history of several years of similar symptoms and had previously undergone stomach resection for cancer. Hospital admission diagnosis was cirrhosis of the liver. Scintigraphy revealed an enlarged liver with pronounced irregularity of colloid distribution. Ultrasound examination showed the liver to be enlarged due to changes in the left lobe. The walls of the intrahepatic biliary ducts were consolidated and the gallbladder was curved. The pancreas had even contours and its head was diffusely consolidated.
  • Transcutaneous transhepatic cholangiography revealed dilatation of the intra and extra hepatic bile ducts and common bile duct obstruction due to tumor constriction.
  • the patient was transferred to radiology with the diagnosis of an obstruction of common bile duct caused by the metastases from the stomach tumor.
  • transcutaneous transhepatic dilatation of the stricture was performed with roentgeno-endobiliary prosthetic placement at the distal end of the obstruction. Prosthetic placement was not performed along the whole length of the stricture because the length of the prosthesis available at the time was insufficient. Therefore, six months later the patient underwent a repeated roentgeno-endobiliary prosthetic placement with a longer prosthesis sized to fit the full length of the stricture.
  • the control cholangiogram showed that the biliary ducts were patent. External drainage was removed on the third day. The cessation of jaundice and decrease in bilirubin level were observed.
  • the spiral was formed with a fixing ring on its distal end. Then it was cooled using chloroethane (C 2 H 5 CI) , straightened, placed on a rod and inserted into the placement catheter. The catheter wa inserted into the body organ to be treated with the fixin ring on the straightened nitinol spiral placed in the area o the lower end of the stricture. The spiral, responding t body heat, began to acquire the previously given shape. Afte the spiral reformed from its low temperature shape, it wa disconnected from the placement rod and the rod was remove from the organ.
  • chloroethane C 2 H 5 CI
  • the stent was twisted on the catheter of th invention into a spiral of a smaller diameter conforming t the catheters outer surface. Following disconnection from th catheter, the spiral enlarged in its diameter as a result o being exposed to the body temperature of the animal and wa fixed inside the body organ (tubular conduit) forming a internal support.
  • the spiral diameter should exceed the diameter of the esophageal stricture or the tubular body organ receiving the implant by 2-3 mm and the diameter of the intact esophagus of rabbits by 3-4 mm to avoid displacement.
  • the spiral diameter for the intact esophagus of rats should exceed the esophageal diameter by a ratio of 1.5.
  • Two months following the procedure the inflammatory infiltration around spiral coils was considerably reduced. Granulations were replaced by fibrous tissue and, by the third month following the procedure, the spaces between the windings of the coil were formed of fibrous tissue with widely scattered single lymphoid cells being encountered.
  • the channels located in the superficial layers of the mucous membrane were covered with multilayer flat epithelium.
  • the walls of the coil were covered either with multilayer flat epithelium (in the mucous membrane) or with fibrous tissue (in the sub ucous membrane) .
  • Example 3A and 3B human clinical REP were performed in 6 patients with esophagus cancer. All 6 were male patients, ages from 44 to 76 years and a mean age of 62. All patients had cancer of the thoracic section of the esophagus extending 50 to 80 mm. Many of the conditions were complicated by advanced age, severe pathology (as a rule cardiovascular) , and metastatic cancer making it impossible to perform radical surgical procedures. The patients also responded negatively to gastrostomy. Taking into account the increasing dysphagia, a nitinol spiral endoprosthesis with lengths ranging from 45 to 80 mm, and diameters from 12 to 20 mm were implanted in each patient. Set forth below is a representative example:
  • Bronchoscopy showed compression of the left main bronchus with the lumen reduced to one-half its normal size.
  • the diagnosis was Squamous cell cancer of the middle third of the esophagus with bronchial segment lesion, T3NxMo with exophytic type of growth with ulceration, chronic cerebrovascular insufficiency, and arteriosclerosis obliterans of the lower extremities vessels.
  • the spiral After being cooled wit chloroethane the spiral was twisted around the placemen catheter into a smaller diameter of 7.0 mm and it was the introduced into the esophagus. Guided by x-ray contrast mark fixed to the patient's skin, the introduction catheter wit the spiral attached was introduced into the stricture with th distal end of the spiral located at the end of the strictur closest to the point of introduction of the placemen catheter. The mandril wire was then withdrawn slightly releasing the proximal end of the spiral. The proximal end of the coil began acquiring the preformed shape under the influence of body temperature. To accelerate the process, 50 ml of water at 40°-50°C, was introduced into the esophagus along the catheter.
  • the mandril wire was fully removed releasing the distal end of the implant, and the placement catheter and locking wire were extracted from the patient.
  • Examination of the esophagus using contrast media showed the dilation of the lumen as expected. Subjectively, the patient felt no pain during the procedure. For the next few days the patient had the feeling of pressure on the esophageal walls in the thorax but it soon disappeared. The patient was then given chemotherapy with methotrexate and spirobromin. The patient reported the ability to ingest fluid and solid food through the esophagus; this was confirmed by clinical observations.
  • nitinol Using ethyl chloride to cool the nitinol it was reshaped for mounting on an 8F placement catheter which was then placed in an artery immediately after it had been expanded by angioplasty, such as the iliac, femoral, popliteal, subclavian, carotid or renal artery (more than 110 clinical implants) .
  • angioplasty such as the iliac, femoral, popliteal, subclavian, carotid or renal artery (more than 110 clinical implants) .
  • Experimental studies were conducted on 36 dogs with placement of 66 endovascular nitinol prostheses. Long term results followed up over a period of 14 months demonstrated acceptable prolonged performance of the nitinol stents. Morphological study showed that stents were separated in a ring-like fashion by a thin layer of connective tissue and the inner lumen of the coil was lined with a layer of epithelial cells.
  • the device and procedure is applicable to the placement of a support structure into any body conduit or tubular organ. It has been demonstrated to be effective for restoring a channel through esophageal tumors, improving flow through diseased blood vessels and bile ducts, the device also has utility in relieving obstructions in the intestinal or urogenital tract or other tubular body conduits or organs. Additionally, its utility is enhanced when combined with balloon dilation or laser recanalization of the obstructed conduit or organ being treated.
  • the dimensions of the catheter, mandril and expandable shunt are varied to fit the organ in which they are being placed. Dimensions of the catheter and mandril are chosen to be comparable to other medical devices for fluid delivery or organ treatment currently used in these organs. The shunt dimensions depend on the size of the organ to be supported.

Abstract

Disclosed is a coil stent constructed from a nitinol alloy having the ends thereof shaped to interact with a placement device specifically designed to hold the stent in a reduced diameter while it is being maniuplated to its desired position in the patient's body. The placement device is a hollow tube which has holes in it surface allowing placement of the ends of the stent therethrough so that they can be held in place inside the interior of the placement device by a mandril which is threaded through the center of the placement device. The combination of the features of the shapes on the end of the stent, the holes in the placement device and the mandril which passes through the placement device and the shapes on the end of the stent allow the interventional radiologist to accurately and rapidly place the stent in its desired position before it changes shape to its final pre-set configuration.

Description

NITINOL STENT SYSTEM FOR HOLLOW BODY CONDUITS
BACKGROUND
The reconstruction of obstructed vital body organs to restore their function is a common and significant surgical task. In order to accomplish this task, surgeons have to perform extensive, traumatic operations with considerable morbidity and significant risk of severe complications and death. Therefore, it is desirable that alternative procedures be developed which allow the achievement of the same purpose with less risk and minimal surgical intervention.
With the advent of interventional radiology, researchers have developed techniques which effect the clearing of obstructions in many body conduits with little, if any, surgical intervention. The present invention relates to an improved nitinol spiral stent for use as an endoprosthesis for reinforcing these body conduits so as to maintain their patency and function. The invention has been demonstrated to have particular utility for repairing narrowed, weakened, distorted, distended or otherwise deformed tubular body conduits, such as those in the vascular, biliary, genitourinary, gastrointestinal and respiratory systems. The invention includes an improved delivery system for placement of the stent.
Previous devices for performing this function have not been designed for easy, controlled placement. Because the prior art stents were not designed to cooperate with specific placement devices and the placement devices were not designed to restrain the stent until properly located, correct placement was difficult to control. Also, prior nitinol stent systems required injection of cold saline, hot saline or both to prevent, control or encourage the transformation of the stent to its pre-set coil shape. This complicated the procedure and subjected the patient's body to unnecessary stress caused by the injection of the hot and cold fluids.
It is known in the art to utilize stents to reinforce tubular body conduits. Dotter (Investicrative Radiology. Sept.-Oct. 1969, pp. 329-332) reported on unsuccessful experimental implantation of impervious plastic tube grafts and silicone coated stainless steel springs. In the same paper he also reported the successful (2.25-2.5 year patency) placement of coil springs made from standard No. 5 stainless steel wire. These coil springs were transported to the body site by a mandril with the coil tightly wrapped on its outer surface.
Additionally, it is known to utilize shape memory materials to fabricate these stents. The shape-memory effect was presented by A. B. Greininger of Harvard and V. G. Mooradian of MIT as early as 1938. Since then, several investigators have shown that there are several different types of alloys which demonstrate this property. More recently, U.S. Patent 4,950,258 describes a molded coil produced from shape-memory polymers of lactide homopolymers, glycolide homopolymers, or copolymers of lactide and glycolide. However, this phenomena was not widely known until 1962 when Buehler announced the development of shape-memory materials prepared from titanium-nickel (TiNi) alloys, usually referred to as nitinol. Shape-memory alloys have the unusual property of mechanical "memory." These materials can be formed into a first predetermined shape above a transition temperature range (TTR) , the TTR being dependent on the particular ratio of metals in the alloy. Below the TTR the alloy is highly ductile and may be plastically deformed into a second desired shape. Upon reheating above the TTR th alloy returns to its first pre-set form.
The general properties of these TiNi shape-memor materials are related in an article by W.J. Buehler, et. al. Wire Journal. June, 1969, pp. 41-49, and more extensivel discussed in an article by McDonald Schetky (Scientifi American, November, 1979, pp. 74-82) . Schetky reviews severa promising medical applications of the TiNi alloys includin mounting means for orthopaedic implants, bone fracture bindin systems, and implantable blood clot filters which can b inserted in a blood vessel through a catheter. These bloo clot filters are further detailed in U.S. Patent 4,425,908 t Simon, U.S. Patent 4,494,531 to Gianturco, and Simon, M. , et al.. Radiology. October, 1977, pp. 89-94.
The Simon device uses a nitinol material with a TTR o 40°-50°F. The alloy, which can be formed into various mesh o filter designs, is reformed into a straight wire in ice-coole water. A stud attached to the rear of the straightened filte wire is engaged in a notch on the guide wire which is the placed in the bore of a Teflon catheter for implantation. Under fluoroscopic control the catheter is advanced to th desired placement location within the blood vessel, and th guide wire and free end of the nitinol wire are extruded fro the catheter. As the straightened nitinol wire become exposed to the temperature of the blood, it reforms into it pre-set filter shape locking it into the blood vessel and, a the notch on the guide wire with inserted stud on th straightened wire are extruded from the placement catheter, the wire automatically becomes disengaged from the placemen device.
Other medical applications of shape-memory alloys i medicine are a prosthetic pump (U.S. Patent 3,827,426), a apparatus for percutaneous catheterization (U.S.Patent 4,411,655), an intrauterine contraceptive device (U.S. Patent 3,620,212), a ring to hold a sewing cuff to an artificial heart valve (U.S. Patent 4,233,690), a catheter or cannula (U.S. Patent 3,890,977), marrow nails (U.S. Patent 4,170,990), and dental arch wires (U.S. Patent 4,037,324). Also, U.S. Patent 4,665,906 addresses the use of stress-induced martensite alloys for the formation of several different medical devices.
Most relevant to the present invention are the products described by Dotter ("Transluminal Expandable Nitinol Coil Stent Grafting: Preliminary Report," Radiology, 147, April, 1983, pp. 259-260 and U.S. Patent 4,503,569), Cragg, et. al., ("Nonsurgical Placement of Arterial Endoprosthesis: A New Technique Using Nitinol Wire," Radiology. 147, April, 1983, pp. 261-263), Alfidi, et. al., U.S. Patent 3,868,956 and Balko (Transfemoral Placement of Intraluminal Polyurethane Prosthesis for Abdominal Aortic Aneurysm, Journal of Surgical Research. 40, April, 1986, pp. 305-309; and U.S. Patent 4,512,338). The Dotter article discloses the use of a nitinol material having a transition temperature of 130°-140°F, thus, requiring an injection of hot saline to cause the material to reform to its coil shape. Despite the specific requirement for hot saline, the Dotter patent claims a nitinol material with a transition temperature in a range at or above normal body temperature. Because the Dotter patent does not incorporate any means to restrain the coil during insertion, the placement procedure requires an initial injection of cold saline to insure the coil does not reform during insertion followed by a second injection of hot saline to encourage reformation. Cragg utilizes a threaded adapter on one end of the coil to hold it during placement. Alfidi discloses an appliance expansible by the application of electrical heating. Balko discloses a nitinol wire with a transition temperature below body temperature. In order t prevent the stent from changing shape while being positione in the body it is enclosed in an insulating sheath.
G. Mednik, in an article entitled "Roentgeno endoesophageal Prosthesing with Nitinol Spiral," published i the Russian journal Surgery. pp. 87-94 (1989) , along wit other clinicians, reports on the use of nitinol stents t clear obstruction in the esophagus of cancer patients. Th placement procedure described therein restrains only one en of the stent, leaving it free to deform as it is heated by th patient's body temperature.
All of the stents described in the prior art patents an articles suffer from the same deficiencies. The stents an delivery systems are not designed to work together to allo accurate and controlled placement of the device. Additionally, while the shape-memory property of the nitino materials is utilized, maximum advantage of this propert cannot be realized because the design of the prior ar delivery systems does not adequately control th transformation of the stent from its cold temperature form t the pre-set form attained above its TTR. A potential proble of nitinol alloys with a high TTR (i.e., 130°-140°F) is the could be easily deformed in situ at body temperature. Unrestrained nitinol stents having a TTR below bod temperature require rapid placement as they will star transforming to their original shapes as soon as they ar introduced into the body or blood stream.
Thus, there is a need for a stent and delivery syste which overcomes these problems. SUMMARY
The present invention is directed to a coil stent constructed from nitinol alloy, the stent having the ends thereof designed to interact with a placement device specifically fabricated to retain the stent in a second smaller diameter while the stent is manipulated to its desired position in the patient's body. Additionally, it is directed to a placement device designed to utilize the structure on the ends of the stent to restrain the stent from reformation until in its desired location.
DRAWINGS
These and other features, aspects and advantages of the present invention will become better understood with reference to the present description, appended claims and accompanying drawings, where:
Figure 1 is a side view of the coil stent in its first or expanded form according to the present invention.
Figure 2 is a vertical cross-sectional perspective view of the stent of Figure 1 taken along line 2-2 of Figure 1.
Figure 3 is a cut away view of the delivery catheter and wire guide according to the present invention.
Figure 4 is a cut away view of a variation of the catheter of Figure 3.
Figure 5 is a partial cut away view of the stent of Figure 1 in its second or delivery shape positioned in the delivery catheter of Figure 3. Figure 6 is a partial cut away view of the stent o Figure 1 in its second or delivery shape positioned in th delivery catheter of Figure 4.
Figure 7 is an enlarged view of a portion of the cathete and stent of Figure 6.
Figure 8 is an enlarged cross-sectional view taken alon line 8-8 of Figure 5.
Figure 9 is a partial sectional view of an arter following angioplasty showing the delivery system of Figure with the stent in the process of reforming to its hig temperature configuration.
DESCRIPTION
Roentgeno-endoprosthetic placement (REP) involves th implantation into vessels and organs of a radiopaqu prosthesis of metal alloy having a shape memory effect. Th placement procedure is performed non-surgically by a interventional radiologist using modern imaging technique which obviate the need to surgically expose the area to b treated. The technique takes advantage of the shape memor behavior of nitinol. When cooled below its TTR, a spiral o nitinol wire can be straightened into a linear configuratio or twisted into a desired shape to fit the profile of th placement device upon which the nitinol wire will be carrie to the body site to be treated. When heated to a temperatur above the alloy TTR, the wire re-acquires its initial shap forming a frame within the body conduit being treated.
The nitinol prosthesis of the invention has the followin characteristics: 1. Biological compatibility. 2. Resistance to corrosion.
3. Capability of placement using a catheter.
4. Accurate adjustment under radiological control.
5. Restoration of shape at a temperature lower than body temperature.
6. Fixation in situ.
7. Maintenance of the shape of vascular biliary, gastrointestinal, genitourinary, respiratory conduits (incompressibility under outside pressure) .
8. Non-absorption of undesirable biological materials to the prosthesis surface, i.e., salts of bile acids, etc.
With reference to the drawings, the stent 10 is composed of a coil 12 constructed from a nickel/titanium metal alloy (nitinol) wire 14 preferably of 55% nickel and 45% titanium. The wire 14 which is formed at a temperature above the TTR of the alloy into its first shape or configuration 16 can be reformed into a second configuration 18 when cooled below the TTR of the alloy. The wire 14 can be returned to its first configuration 16 by exposure to a specified higher temperature above the alloy TTR. Figure 1 shows the stent 10 comprising a spiral of nitinol wire 14 in its first coiled configuration 16. Loops or hooks 20 as shown in Figures 1, 5, 6 and 8 are formed in the proximal and distal ends 22 and 24 to hold the wire 14 in place after placement on the delivery catheter 30.
In prior art devices, because the coil 12 was not restrained, the configuration could change during introduction of the coil into the body as the device warmed in response to body temperature. An uncontrolled change in configuration could result in damage to the vessel or other body conduit. Because the implant was not restrained, there was also a possibility that the endoprosthesis would not be precisely placed. Lack of precision could cause harm and/or lead to a unintended result. Thus, a metal alloy having a TTR close t normal body temperature was desired to delay or minimize shape change while the stent was being implanted.
The endoprosthesis can also incorporate a silicone o other suitable biocompatible coating. This coating reduce the chance of thrombosis in treated blood vessels or adherenc of food, bile, and genito-urinary deposits on the coil whic would impair the function of the vessels or tubular structur when implanted therein. If undesired depositions occur, partial or complete blockage of the treated vessel or tubula system can result, leading to jeopardy to life and limb. Th coating must be chosen for the body system into which th stent will be placed. For example, coatings suitable fo placement in arterial or venous blood vessels may not b suitable for genito-urethral tracts or the respiratory system. Appropriate coatings include, but are not limited to, silicon rubbers, hydrophilic polymers, biological coatings, such a heparin or other polysaccharides, collagen and other relate materials which are known to retard deposition of undesirabl materials, encourage desired tissue ingrowth or stimulate th deposition of preferential biological constituents.
While products are usually composed of wire with a circular cross-section, further improvement, shown in Figure 2, comprises utilization of a rectangular cross-section 26 fo the wire which makes up the coil. This results in a tighter junction between adjacent loops in the coil which decreases or prevents ingrowth of invasive cancer tissue through the implanted device or deposition of undesirable blood components on underlying tissue damaged by angioplasty or other procedures used to clear clogged blood vessels.
Also presented is a new and novel delivery system 30 for inserting the coil 12 which uses retention means such as fixing loops or hooks 20 at each end of the coil 10. This delivery system 30 includes a tubular placement device, such as a catheter 32, which has proximal and distal cut-outs or holes 34 and 36 in its outer surface 38, allowing the loops or hooks 20 to be inserted through the wall 40 of the catheter 32 and into the bore or lumen 42 of the catheter 32 where they can be traversed or pierced by a central mandril or guide wire 44 placed within the bore of the catheter 32 as shown in Figure 5. The preferred design utilizes a catheter with an opening 35 in its proximal end so that the guide wire 44 can extend out of the"catheter and through a constriction which will receive the stent. Placement of the mandril 44 through the loops 20 on the proximal and distal ends 22 and 24 of the coil 12 holds the wire 14 in its second configuration 18 so that it cannot reform to its first configuration 16 or be dislodged until the mandril 44 is withdrawn, thus ensuring proper positioning of the stent 10 in its desired final location. While not necessary, within the bore 42 of the catheter 32 at approximately the location of the proximal and distal cut-outs 34 and 36 are circular grooves 48 which allow additional space within the catheter 32 for the loops 20 as shown in cross-sectional view of Figure 8. Holding the wire 14 in its second configuration 18 (cold temperature shape) until located in the desired position and then releasing the proximal end 22 of the wire by slightly withdrawing the mandril 44 from its position within the loop 20 on the proximal end 22 allows the wire 14 to reform into its first configuration 16 at the exact desired location in the body, greatly enhancing the effectiveness and safety of the stent 10 and the placement procedure.
Figures 4 and 6 show a modification of the delivery system 30 which incorporates a depressed region 46 in and fully encircling the outer surface 38 of the catheter 32. The purpose of the depressed region 46 is to allow the wire 14 t be wrapped around the catheter 32 while still retaining th uniform outer profile of the catheter 32. As can be seen i Figure 5, when the wire 14 is wound on the catheter 32 o Figure 3, the wire increases the diameter of the system. Th depressed region 46, as shown in Figures 6 and 7, allows th wire 14 to be wrapped on the catheter 32 without increasin the outer diameter of the system, thus, making it easier t insert the system into the desired body organ.
The procedure for placing the stent 10, using th delivery system 30 of the present invention, within a bloo vessel, for example, an artery following an angioplast procedure, is as follows: 1. A wire 14 formed from a nitinol alloy with a TTR a or below body temperature is heated above its TTR to temperature necessary to form a first configuration, i.e., coil as shown in Figure 1. A suitable form is a closel spaced coil, preferably with the coil turns touching eac other, having an outer diameter slightly greater than th inner diameter of the vessel into which it will be placed. loop or hook 20 is formed on each end of the wire. This ca be accomplished in the hospital facility if suitable heatin and forming equipment is available. Alternatively, the sten is supplied by the manufacturer in a range of pre-set oute diameters so that the interventional radiologist can selec the dimensions most suited to the patient's needs.
2. The formed coil is then cooled below the TTR of th alloy so that it can be reshaped into a desired secon configuration.
3. The loop 20 on the distal end 24 is placed throug the distal cut-out 36 of the catheter 32 into the circula groove 48 and the mandril tip 45 is threaded through loop 14
4. The wire is spirally wound tightly around the oute surface 38 of the depressed region 46 of the catheter 32, th loop 20 on the proximal end 22 of the wire 14 is inserted through proximal cut-out 34, and the mandril tip 45 is advanced through the loop 20 into the proximal end of the catheter 32. 5. The delivery system 30 with the wire 14 in its second configuration 18 is then introduced into the body, using readily available catheter introduction system, and advanced to the site for stent 10 placement under fluoroscopic or other nonsurgical visualization procedures. 6. When the distal end 24 of the wire 14 is located at the distal end of the chosen delivery site the mandril 44 is partially withdrawn, freeing the proximal end 22 of the wire 14.
7. Having been exposed to body temperature, which is above the TTR of the alloy, the wire 14 will immediately reform into its first configuration 16 (a coil of outer diameter greater than the vessel in which it is placed) .
8. Once the proximal end is sufficiently reformed to hold the stent 10 in the vessel, as shown in Figure 9, the mandril 44 can be withdrawn from the loop 20 on the distal end 24 of the wire 14. If the stent 10 is not properly positioned, it can be moved and repositioned before the mandril 44 is withdrawn from the distal loop.
Alternatively, the hook and loop 20 can be formed on the ends of the wire while it is in its second low temperature configuration.
In a like manner, the stent can be positioned in various tubular or hollow body conduits or organs.
The delivery system 30 for the improved nitinol stents 10 takes advantage of the fixing loops 20 at both ends of the coil 12. Specifically, this delivery system 30 comprises both a catheter 32 and guide wire 14, with the overall system having a significantly smaller diameter than the prior ar delivery systems. The catheter 32 of the improved deliver system 30 has at least two cut-outs 34 and 36 in its oute surface 38 enabling the loops (or hooks) 20 to be place through the wall 40 of the catheter 32 and then traversed b a central guide wire 44 placed within the catheter 32. Th placement of the central guide wire 44 through the cathete lumen 42 and the loops or hooks 20 placed therein affixes th coil 12 so that it cannot reform or be dislodged until th guide wire 14 is withdrawn. This ensures proper positionin prior to release of the endoprosthesis (stent 10) , allows th stent to be withdrawn or repositioned if problems occur durin the procedure, thus, greatly enhancing the effectiveness an safety of the procedure.
Additional beneficial features of the delivery system ar reduction of friction and an increase in flexibility an steerability. The coating on the product, while reducin deposits on the system, also reduces friction as the system is manipulated to its desired location. The smaller diameter of the catheter and the commensurate flexibility, in combination with standard catheter steering techniques, allows the interventional radiologist to readily manipulate the catheter through stenotic (narrow) passages and to bend the catheter to direct the endoprosthesis to its desired location, thus, allowing access to regions that are difficult to access due to the tortuous course between the sites of introduction and implantation.
As a further improvement, an angioplasty balloon can be combined with the nitinol endoprosthesis. Specifically, this improvement incorporates an angioplasty balloon on a catheter having two or more inner channels. One channel is for inflating the angioplasty balloon and a second channel is for insertion of the wire guide to catch the terminal loops of the nitinol stent. Contrast media or other liquids can be injected through a third channel or through the channel used for the wire guide.
The combined system allows the interventional radiologist to perform balloon dilatation of a hollow body conduit and place the nitinol stent in a single, controlled nonsurgical procedure with one instrument through a single access site. This ensures greatly enhanced effectiveness and safety of the balloon dilatation procedure and proper positioning prior to the release of the stent, all in rapid succession.
EXAMPLE 1
Transcutaneous implantation of an endobiliary prosthesis in patients was performed as follows:
1. A metal guide was introduced beyond the stricture area using a previously placed external drainage catheter.
2. Using the Seldinger procedure, the external drainage tube was replaced by a transport catheter, the tip of which was placed immediately proximal of the stricture.
3. A coiled nitinol endobiliary prosthesis, fixed on the placement system described above, was introduced through the lumen of the transport catheter so that the end fixed in the proximal cut-out is located at the proximal stricture end.
4. The transport catheter was then removed so that the prosthesis, still mounted on the delivery catheter remained in the lumen of bile duct and across the stricture.
5. The forward loop was then released by slightly withdrawing the guide wire. Under body temperature, the prosthesis reformed to its pre-set spiral shape with a predetermined diameter slightly larger than the biliary tract. 6. Once the prosthesis was accurately fixed in the stricture, the second loop was released and the guide wire wa removed.
7. The transport catheter was then replaced by a external drainage device which was removed seven days afte the procedure.
EXAMPLE 2
Twenty-six experimental (animal) and 17 clinical endobiliary replacements were conducted using nitinol stent incorporating the invention described above and the procedur of Example 1. The procedure, as applied to one of th patients in this clinical study was as follows:
A 37-year old male was admitted to the hospital with symptoms of jaundice, weakness, pruritus and nausea. He had a history of several years of similar symptoms and had previously undergone stomach resection for cancer. Hospital admission diagnosis was cirrhosis of the liver. Scintigraphy revealed an enlarged liver with pronounced irregularity of colloid distribution. Ultrasound examination showed the liver to be enlarged due to changes in the left lobe. The walls of the intrahepatic biliary ducts were consolidated and the gallbladder was curved. The pancreas had even contours and its head was diffusely consolidated. Transcutaneous transhepatic cholangiography revealed dilatation of the intra and extra hepatic bile ducts and common bile duct obstruction due to tumor constriction. The patient was transferred to radiology with the diagnosis of an obstruction of common bile duct caused by the metastases from the stomach tumor. Under local anaesthesia, transcutaneous transhepatic dilatation of the stricture was performed with roentgeno-endobiliary prosthetic placement at the distal end of the obstruction. Prosthetic placement was not performed along the whole length of the stricture because the length of the prosthesis available at the time was insufficient. Therefore, six months later the patient underwent a repeated roentgeno-endobiliary prosthetic placement with a longer prosthesis sized to fit the full length of the stricture.
The control cholangiogram showed that the biliary ducts were patent. External drainage was removed on the third day. The cessation of jaundice and decrease in bilirubin level were observed.
Clinical Results
Before After
Procedure Procedure Normal
Total bilirubin 176.7 mol/L 1.0 (0.6-0.8)
Direct bilirubin 194.4 m mol/L 1.4 (0.6-0.8)
Indirect bilirubin 82.3 m mol/L 0.4 (0.6-0.8)
One year after the procedure the patient continues to exhibit improvement over his pre-procedure condition.
The results clearly indicate that the procedure was effective and had continuing beneficial results.
EXAMPLE 3
During animal investigations 2 techniques of esophageal placement of stents (REP) were developed.
A. In the first technique, the spiral was formed with a fixing ring on its distal end. Then it was cooled using chloroethane (C2H5CI) , straightened, placed on a rod and inserted into the placement catheter. The catheter wa inserted into the body organ to be treated with the fixin ring on the straightened nitinol spiral placed in the area o the lower end of the stricture. The spiral, responding t body heat, began to acquire the previously given shape. Afte the spiral reformed from its low temperature shape, it wa disconnected from the placement rod and the rod was remove from the organ.
B. In the second technique, rather than full straightening the nitinol spiral after cooling wit chloroethane, the stent was twisted on the catheter of th invention into a spiral of a smaller diameter conforming t the catheters outer surface. Following disconnection from th catheter, the spiral enlarged in its diameter as a result o being exposed to the body temperature of the animal and wa fixed inside the body organ (tubular conduit) forming a internal support.
All the stages of the procedure were conducted unde direct x-ray imaging control. After the spiral was reforme in situ a control electroroentgenogram was performed an follow-up roentgenoscopy was performed at various intervals thereafter. Displacement of the nitinol spiral was observed in 3 of 5 rabbits with esophageal burn stricture and in 3 of 20 rabbits with an intact esophagus. No rabbits wit surgically caused esophageal strictures showed a shifting of the implanted spiral. Displacement of the spiral was observed in 8 of 37 rats. Based on the animal experiments it was concluded that the spiral diameter should exceed the diameter of the esophageal stricture or the tubular body organ receiving the implant by 2-3 mm and the diameter of the intact esophagus of rabbits by 3-4 mm to avoid displacement. The spiral diameter for the intact esophagus of rats should exceed the esophageal diameter by a ratio of 1.5. Two months following the procedure, the inflammatory infiltration around spiral coils was considerably reduced. Granulations were replaced by fibrous tissue and, by the third month following the procedure, the spaces between the windings of the coil were formed of fibrous tissue with widely scattered single lymphoid cells being encountered. The channels located in the superficial layers of the mucous membrane were covered with multilayer flat epithelium.
Depending on the depth of impression of the spiral coils, the walls of the coil were covered either with multilayer flat epithelium (in the mucous membrane) or with fibrous tissue (in the sub ucous membrane) .
EXAMPLE 4
Based on the results of the animal experimentation set forth in Example 3A and 3B human clinical REP were performed in 6 patients with esophagus cancer. All 6 were male patients, ages from 44 to 76 years and a mean age of 62. All patients had cancer of the thoracic section of the esophagus extending 50 to 80 mm. Many of the conditions were complicated by advanced age, severe pathology (as a rule cardiovascular) , and metastatic cancer making it impossible to perform radical surgical procedures. The patients also responded negatively to gastrostomy. Taking into account the increasing dysphagia, a nitinol spiral endoprosthesis with lengths ranging from 45 to 80 mm, and diameters from 12 to 20 mm were implanted in each patient. Set forth below is a representative example:
Patient 1, 62-years old, complained of difficulty in passing solid and fluid food along the esophagus, weakness, hoarseness, cough, and pain in the thorax with radiation into the interscapular area. Medical consultation was sought three months after the patient noted the onset of the pains in the thorax. X-ray examination showed a 75 mm tumor of the bronchial segment of the esophagus with an ulceration of 25x10x10 mm. Esophagoscopy showed round, whitish, easily bleeding formations ranging in size from 22 to 29 cm. There also was a dramatic circumferential stenosis of the esophageal lumen. Bronchoscopy showed compression of the left main bronchus with the lumen reduced to one-half its normal size. The diagnosis was Squamous cell cancer of the middle third of the esophagus with bronchial segment lesion, T3NxMo with exophytic type of growth with ulceration, chronic cerebrovascular insufficiency, and arteriosclerosis obliterans of the lower extremities vessels.
Taking into account the patient's age, concomitan pathology, radiologic and bronchologic signs, th impossibility of re-secting the tumor, and increasin dysphagia, it was decided to perform REP of the cancerou esophageal stricture with a spiral nitinol prosthesis of th present invention and to apply chemotherapy. Premedication wa relanium 2.5 ml, atropinium 1.0 ml. Under x-ray control balloon dilatation of the stricture was performed followed b the above-described catheter introducer with a twisted nitino spiral mounted on its outer surface. The preforme endoprosthetic replacement consisted of a spiral with a 60 m length and a 20 mm diameter. After being cooled wit chloroethane the spiral was twisted around the placemen catheter into a smaller diameter of 7.0 mm and it was the introduced into the esophagus. Guided by x-ray contrast mark fixed to the patient's skin, the introduction catheter wit the spiral attached was introduced into the stricture with th distal end of the spiral located at the end of the strictur closest to the point of introduction of the placemen catheter. The mandril wire was then withdrawn slightly releasing the proximal end of the spiral. The proximal end of the coil began acquiring the preformed shape under the influence of body temperature. To accelerate the process, 50 ml of water at 40°-50°C, was introduced into the esophagus along the catheter. After full expansion of the coil to its preformed shape the mandril wire was fully removed releasing the distal end of the implant, and the placement catheter and locking wire were extracted from the patient. Examination of the esophagus using contrast media showed the dilation of the lumen as expected. Subjectively, the patient felt no pain during the procedure. For the next few days the patient had the feeling of pressure on the esophageal walls in the thorax but it soon disappeared. The patient was then given chemotherapy with methotrexate and spirobromin. The patient reported the ability to ingest fluid and solid food through the esophagus; this was confirmed by clinical observations.
EXAMPLE 5
Using ethyl chloride to cool the nitinol it was reshaped for mounting on an 8F placement catheter which was then placed in an artery immediately after it had been expanded by angioplasty, such as the iliac, femoral, popliteal, subclavian, carotid or renal artery (more than 110 clinical implants) . Experimental studies were conducted on 36 dogs with placement of 66 endovascular nitinol prostheses. Long term results followed up over a period of 14 months demonstrated acceptable prolonged performance of the nitinol stents. Morphological study showed that stents were separated in a ring-like fashion by a thin layer of connective tissue and the inner lumen of the coil was lined with a layer of epithelial cells.
The animal research and human clinical trials proved validity of the above-described invention and procedure, the ease of use, the accuracy and reliability of placement, and the biological compatibility of nitinol. The device and procedure is applicable to the placement of a support structure into any body conduit or tubular organ. It has been demonstrated to be effective for restoring a channel through esophageal tumors, improving flow through diseased blood vessels and bile ducts, the device also has utility in relieving obstructions in the intestinal or urogenital tract or other tubular body conduits or organs. Additionally, its utility is enhanced when combined with balloon dilation or laser recanalization of the obstructed conduit or organ being treated.
Because the system described herein has utility for supporting numerous body organs of various different sizes, the dimensions of the catheter, mandril and expandable shunt are varied to fit the organ in which they are being placed. Dimensions of the catheter and mandril are chosen to be comparable to other medical devices for fluid delivery or organ treatment currently used in these organs. The shunt dimensions depend on the size of the organ to be supported.
Testing has shown that the use of a nitinol spiral in combination with the delivery system of the invention for endoprosthetic placement is a minimally traumatic, relatively bloodless technique which can be applied without general anesthesia for improving the patency of body conduits and tubular organs.

Claims

What is claimed is:
1. A system for positioning in a hollow body organ an expandable stent having a first retention means formed on one end of the stent and a second retention means formed on the second end of the stent comprising: an elongated tube having a proximal end for placement into the hollow body organ, a distal end spaced from the proximal end, and a lumen extending through the tube from the proximal end to the distal end, said elongated tube having a first and second hole in the surface thereof, said holes being separated from each other along the length of the tube and being located between the distal end and the proximal end of the tube, the holes extending from the exterior of the tube into the lumen and being sized so that the first retention means can be inserted through the first hole into the lumen and the second retention means can be inserted through the second hole into the lumen, a removable mandril extending through the lumen from at least the distal end to the proximal end of the tube, the mandril being sized to interlock with the first and second retention means on the stent.
2. The system of claim 1 wherein the outer diameter of the tube between the first and second hole is smaller than the outer diameter of the remainder of the tube.
3. The system of claim 1 wherein the lumen has a uniform diameter throughout the length of the catheter.
4. The system of claim 3 wherein the lumen has an enlarged diameter at the location of the first and second hole.
5. A system for placing a support at a desired locatio in a tubular body organ comprising: an elongated catheter having a proximal end fo placement in the tubular body organ and a distal en spaced from the proximal end so that after placement o the proximal end in the tubular body organ at the desire location, the distal end extends out of the tubular bod organ, at least one lumen extending through the cathete from the proximal end to the distal end, a first and second cut-out, each cut-out extendin through the wall of the catheter into the lumen, th first cut-out being located near the proximal end of the catheter, the second cut-out being located distal t the first cut-out.
an expandable stent comprising a wire of a fixed length having first and second attachment means formed on the ends of the wire, the wire being spirally wound around the outer surface of the catheter with the first attachment means being placed through the first cut-out and the second attachment means being placed through the second cut-out, an elongated removable mandril extending through the catheter lumen from the distal end at least past the first cut-out, the mandril retaining the first and second attachment means in the lumen in a releasable manner.
6. The system for placing a support of claim 5 wherein the wire is composed of a shape memory alloy which can be formed into a spiral conforming to the outer surface of the catheter at a first temperature and which reforms into a shape of dimensions different from the spiral by exposing the wire to a second temperature higher than the first temperature.
7. The wire of claim 6 wherein the shape memory alloy has a transition temperature range less than the normal temperature of the human body.
8. The wire of claim 7 wherein the alloy is nitinol.
9. A method of placing an internal support into a hollow structure utilizing a tubular placement device comprising: forming a fixed length wire of a shape memory alloy into a first shape sized to fit within and support the hollow structure, said wire having first and second retention means on the ends thereof, cooling the wire to a temperature below the transition temperature range of the shape memory alloy, placing the first retention means through a first opening in the wall of the tubular placement device, securing the first retention means within the lumen of the tubular placement device by advancing a mandril along a portion of the length of the lumen and through the retention means, wrapping the wire around the outer surface of the tubular placement device and placing the second retention means through a second opening in the wall of the tubular placement device into the lumen, securing the second retention means in the lumen by advancing the mandril further along the length of the tubular placement device through the second retention means and past the second opening, advancing the tubular placement device with the wire wound on its outer surface into the hollow structure until the first retention means is at a desired location in the hollow structure,
releasing the second retention means by withdrawing the proximal end of the mandril to a point between the first and second opening in the wall, allowing the wire to at least partially reform to its first structure an amount sufficient to retain the wire within the hollow structure, said reformation being caused by exposing the wire to a temperature greater than the transition temperature range of the alloy, releasing the first retention means by withdrawing the mandril past the first opening, and withdrawing the tubular placement device and mandril from the hollow structure.
10. The method of claim 9 wherein the hollow structure is a tubular organ in the human body and the tubular placement device is a catheter sized to fit within the tubular organ.
PCT/US1992/004899 1991-06-12 1992-06-10 Nitinol stent system for hollow body conduits WO1992022263A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
DE69222305T DE69222305T2 (en) 1991-06-12 1992-06-10 EXTENSION SYSTEM FOR HOLLOW BODY LINES
EP92914225A EP0588959B1 (en) 1991-06-12 1992-06-10 Stent system for hollow body conduits

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US713,770 1991-06-12
US07/713,770 US5147370A (en) 1991-06-12 1991-06-12 Nitinol stent for hollow body conduits

Publications (2)

Publication Number Publication Date
WO1992022263A2 true WO1992022263A2 (en) 1992-12-23
WO1992022263A3 WO1992022263A3 (en) 1993-03-04

Family

ID=24867475

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1992/004899 WO1992022263A2 (en) 1991-06-12 1992-06-10 Nitinol stent system for hollow body conduits

Country Status (6)

Country Link
US (1) US5147370A (en)
EP (1) EP0588959B1 (en)
AT (1) ATE158161T1 (en)
AU (1) AU2237792A (en)
DE (1) DE69222305T2 (en)
WO (1) WO1992022263A2 (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2270264B (en) * 1992-09-02 1996-09-25 Ellis Dev Ltd Palliative stent and insertion device
US5641373A (en) * 1995-04-17 1997-06-24 Baxter International Inc. Method of manufacturing a radially-enlargeable PTFE tape-reinforced vascular graft
AU689096B2 (en) * 1993-01-27 1998-03-26 Intra Therapeutics, Inc. Vascular and coronary stents
US6514285B1 (en) 1993-03-11 2003-02-04 Medinol Ltd. Stent
WO2003041615A1 (en) * 2001-11-12 2003-05-22 Dendron Gmbh Medical implant
US6863686B2 (en) 1995-04-17 2005-03-08 Donald Shannon Radially expandable tape-reinforced vascular grafts

Families Citing this family (425)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5571169A (en) * 1993-06-07 1996-11-05 Endovascular Instruments, Inc. Anti-stenotic method and product for occluded and partially occluded arteries
US5622188A (en) * 1989-08-18 1997-04-22 Endovascular Instruments, Inc. Method of restoring reduced or absent blood flow capacity in an artery
IL94138A (en) * 1990-04-19 1997-03-18 Instent Inc Device for the treatment of constricted fluid conducting ducts
US5429127A (en) * 1991-09-12 1995-07-04 The United States Of America As Represented By The Department Of Health And Human Services Thin wall endotracheal tube
US5500013A (en) * 1991-10-04 1996-03-19 Scimed Life Systems, Inc. Biodegradable drug delivery vascular stent
US5242452A (en) * 1991-10-11 1993-09-07 Kanji Inoue Device for collapsing an appliance collapsible for insertion into human organs
US5372600A (en) * 1991-10-31 1994-12-13 Instent Inc. Stent delivery systems
DK0791333T3 (en) * 1991-12-12 2000-05-01 Target Therapeutics Inc Several extruder-carocclusion coil construction with interlocking coupling
AU666554B2 (en) * 1992-05-11 1996-02-15 Harold Jacob improved biliary catheter
US6770066B1 (en) 1992-05-11 2004-08-03 Ballard Medical Products Multi-lumen endoscopic catheter
US5772668A (en) * 1992-06-18 1998-06-30 American Biomed, Inc. Apparatus for placing an endoprosthesis
US5290295A (en) * 1992-07-15 1994-03-01 Querals & Fine, Inc. Insertion tool for an intraluminal graft procedure
US5306294A (en) * 1992-08-05 1994-04-26 Ultrasonic Sensing And Monitoring Systems, Inc. Stent construction of rolled configuration
US5366473A (en) * 1992-08-18 1994-11-22 Ultrasonic Sensing And Monitoring Systems, Inc. Method and apparatus for applying vascular grafts
US5350419A (en) * 1992-09-18 1994-09-27 Ethicon, Inc. Cardiac pacing lead
US5690666A (en) * 1992-11-18 1997-11-25 Target Therapeutics, Inc. Ultrasoft embolism coils and process for using them
US5348017A (en) * 1993-01-19 1994-09-20 Cardiovascular Imaging Systems, Inc. Drive shaft for an intravascular catheter system
JP3345147B2 (en) * 1993-01-26 2002-11-18 テルモ株式会社 Vasodilators and catheters
US5643309A (en) * 1993-03-25 1997-07-01 Myler; Richard Cardiovascular stent and retrieval apparatus
US5474563A (en) * 1993-03-25 1995-12-12 Myler; Richard Cardiovascular stent and retrieval apparatus
IL109169A (en) * 1993-03-30 1999-06-20 Instent Inc Temporary stent system
US6090115A (en) * 1995-06-07 2000-07-18 Intratherapeutics, Inc. Temporary stent system
US5716410A (en) * 1993-04-30 1998-02-10 Scimed Life Systems, Inc. Temporary stent and method of use
US5282472A (en) * 1993-05-11 1994-02-01 Companion John A System and process for the detection, evaluation and treatment of prostate and urinary problems
US5456667A (en) * 1993-05-20 1995-10-10 Advanced Cardiovascular Systems, Inc. Temporary stenting catheter with one-piece expandable segment
US5514115A (en) * 1993-07-07 1996-05-07 Device For Vascular Intervention, Inc. Flexible housing for intracorporeal use
US5480434A (en) * 1993-07-13 1996-01-02 The University Of Miami Method and device for connecting biological duct to a prosthesis
ATE502664T1 (en) * 1993-07-19 2011-04-15 Angiotech Pharm Inc METHOD OF PRODUCTION OF A STENT WITH ANTI-ANGIOGENIC COMPOSITION
US5735892A (en) * 1993-08-18 1998-04-07 W. L. Gore & Associates, Inc. Intraluminal stent graft
AU726730B2 (en) * 1994-01-28 2000-11-16 Pharmacia & Upjohn Company Delta 12,13-iso-taxol analogs, antineoplastic use and pharmaceutical compositions containing them
ES2075812B1 (en) * 1994-02-25 1996-05-16 De La Torre Fernando Izquierdo LONG DURATION URETERAL PROSTHESIS.
IL108832A (en) * 1994-03-03 1999-12-31 Medinol Ltd Urological stent and deployment device therefor
US5584695A (en) * 1994-03-07 1996-12-17 Memory Medical Systems, Inc. Bone anchoring apparatus and method
US6001123A (en) * 1994-04-01 1999-12-14 Gore Enterprise Holdings Inc. Folding self-expandable intravascular stent-graft
US6165210A (en) * 1994-04-01 2000-12-26 Gore Enterprise Holdings, Inc. Self-expandable helical intravascular stent and stent-graft
US5693085A (en) * 1994-04-29 1997-12-02 Scimed Life Systems, Inc. Stent with collagen
US5554181A (en) * 1994-05-04 1996-09-10 Regents Of The University Of Minnesota Stent
WO1995031945A1 (en) 1994-05-19 1995-11-30 Scimed Life Systems, Inc. Improved tissue supporting devices
US5683451A (en) * 1994-06-08 1997-11-04 Cardiovascular Concepts, Inc. Apparatus and methods for deployment release of intraluminal prostheses
DE69518275T3 (en) 1994-06-08 2007-10-18 CardioVascular Concepts, Inc., Portola Valley Blood vessel graft
US5824041A (en) * 1994-06-08 1998-10-20 Medtronic, Inc. Apparatus and methods for placement and repositioning of intraluminal prostheses
DE69528216T2 (en) * 1994-06-17 2003-04-17 Terumo Corp Process for the production of a permanent stent
US5575816A (en) * 1994-08-12 1996-11-19 Meadox Medicals, Inc. High strength and high density intraluminal wire stent
US6331188B1 (en) 1994-08-31 2001-12-18 Gore Enterprise Holdings, Inc. Exterior supported self-expanding stent-graft
US6015429A (en) * 1994-09-08 2000-01-18 Gore Enterprise Holdings, Inc. Procedures for introducing stents and stent-grafts
US5723003A (en) * 1994-09-13 1998-03-03 Ultrasonic Sensing And Monitoring Systems Expandable graft assembly and method of use
EP0794726A4 (en) * 1994-10-20 1998-01-07 Instent Inc Cystoscope delivery system
US5578074A (en) * 1994-12-22 1996-11-26 Target Therapeutics, Inc. Implant delivery method and assembly
US5601538A (en) * 1995-03-07 1997-02-11 Medtronic, Inc. Flow directed catheter with hydrophilic distal end
US5645558A (en) * 1995-04-20 1997-07-08 Medical University Of South Carolina Anatomically shaped vasoocclusive device and method of making the same
US6171326B1 (en) 1998-08-27 2001-01-09 Micrus Corporation Three dimensional, low friction vasoocclusive coil, and method of manufacture
US8790363B2 (en) * 1995-04-20 2014-07-29 DePuy Synthes Products, LLC Three dimensional, low friction vasoocclusive coil, and method of manufacture
US6638291B1 (en) 1995-04-20 2003-10-28 Micrus Corporation Three dimensional, low friction vasoocclusive coil, and method of manufacture
US5807398A (en) * 1995-04-28 1998-09-15 Shaknovich; Alexander Shuttle stent delivery catheter
US6027516A (en) * 1995-05-04 2000-02-22 The United States Of America As Represented By The Department Of Health And Human Services Highly elastic, adjustable helical coil stent
IL113723A (en) * 1995-05-14 2002-11-10 Optonol Ltd Intraocular implant
CN1283324C (en) * 1995-05-14 2006-11-08 奥普通诺尔有限公司 Intraocular implant, delivery device, and method of implantation
US5968058A (en) * 1996-03-27 1999-10-19 Optonol Ltd. Device for and method of implanting an intraocular implant
WO1996036297A1 (en) * 1995-05-19 1996-11-21 Kanji Inoue Transplantation instrument, method of bending same and method of transplanting same
US6176240B1 (en) 1995-06-07 2001-01-23 Conceptus, Inc. Contraceptive transcervical fallopian tube occlusion devices and their delivery
US6705323B1 (en) 1995-06-07 2004-03-16 Conceptus, Inc. Contraceptive transcervical fallopian tube occlusion devices and methods
US6010530A (en) * 1995-06-07 2000-01-04 Boston Scientific Technology, Inc. Self-expanding endoluminal prosthesis
US5749918A (en) * 1995-07-20 1998-05-12 Endotex Interventional Systems, Inc. Intraluminal graft and method for inserting the same
US5669924A (en) * 1995-10-26 1997-09-23 Shaknovich; Alexander Y-shuttle stent assembly for bifurcating vessels and method of using the same
US6287315B1 (en) * 1995-10-30 2001-09-11 World Medical Manufacturing Corporation Apparatus for delivering an endoluminal prosthesis
US6991614B2 (en) 1995-11-07 2006-01-31 Boston Scientific Scimed, Inc. Ureteral stent for improved patient comfort
US6042605A (en) 1995-12-14 2000-03-28 Gore Enterprose Holdings, Inc. Kink resistant stent-graft
EP0950385A3 (en) 1995-12-14 1999-10-27 Prograft Medical, Inc. Stent-graft deployment apparatus and method
US5713949A (en) * 1996-08-06 1998-02-03 Jayaraman; Swaminathan Microporous covered stents and method of coating
US6702846B2 (en) 1996-04-09 2004-03-09 Endocare, Inc. Urological stent therapy system and method
US6413269B1 (en) 2000-07-06 2002-07-02 Endocare, Inc. Stent delivery system
US6629981B2 (en) 2000-07-06 2003-10-07 Endocare, Inc. Stent delivery system
US5830179A (en) * 1996-04-09 1998-11-03 Endocare, Inc. Urological stent therapy system and method
US5833699A (en) * 1996-04-10 1998-11-10 Chuter; Timothy A. M. Extending ribbon stent
US5979456A (en) * 1996-04-22 1999-11-09 Magovern; George J. Apparatus and method for reversibly reshaping a body part
US6190402B1 (en) * 1996-06-21 2001-02-20 Musc Foundation For Research Development Insitu formable and self-forming intravascular flow modifier (IFM) and IFM assembly for deployment of same
US5941895A (en) * 1996-09-04 1999-08-24 Hemodynamics, Inc. Cardiovascular stent and retrieval apparatus
US5817057A (en) * 1996-09-13 1998-10-06 Micro Interventional Systems, Inc. Fluid propulsion steerable catheter and method
US6254628B1 (en) * 1996-12-09 2001-07-03 Micro Therapeutics, Inc. Intracranial stent
US5843119A (en) * 1996-10-23 1998-12-01 United States Surgical Corporation Apparatus and method for dilatation of a body lumen and delivery of a prothesis therein
US6036702A (en) 1997-04-23 2000-03-14 Vascular Science Inc. Medical grafting connectors and fasteners
US6120432A (en) * 1997-04-23 2000-09-19 Vascular Science Inc. Medical grafting methods and apparatus
US5976178A (en) * 1996-11-07 1999-11-02 Vascular Science Inc. Medical grafting methods
US6080160A (en) * 1996-12-04 2000-06-27 Light Sciences Limited Partnership Use of shape memory alloy for internally fixing light emitting device at treatment site
US7073504B2 (en) 1996-12-18 2006-07-11 Ams Research Corporation Contraceptive system and method of use
US20010041900A1 (en) * 1999-12-21 2001-11-15 Ovion, Inc. Occluding device and method of use
US6352561B1 (en) * 1996-12-23 2002-03-05 W. L. Gore & Associates Implant deployment apparatus
US6551350B1 (en) 1996-12-23 2003-04-22 Gore Enterprise Holdings, Inc. Kink resistant bifurcated prosthesis
US5925061A (en) * 1997-01-13 1999-07-20 Gore Enterprise Holdings, Inc. Low profile vascular stent
US8353948B2 (en) 1997-01-24 2013-01-15 Celonova Stent, Inc. Fracture-resistant helical stent incorporating bistable cells and methods of use
CN1626048B (en) * 1997-01-24 2012-09-12 帕拉贡知识产权有限责任公司 Expandable device having bistable spring construction
US8663311B2 (en) 1997-01-24 2014-03-04 Celonova Stent, Inc. Device comprising biodegradable bistable or multistable cells and methods of use
US5827321A (en) * 1997-02-07 1998-10-27 Cornerstone Devices, Inc. Non-Foreshortening intraluminal prosthesis
US20040267350A1 (en) * 2002-10-30 2004-12-30 Roubin Gary S. Non-foreshortening intraluminal prosthesis
US5893869A (en) * 1997-02-19 1999-04-13 University Of Iowa Research Foundation Retrievable inferior vena cava filter system and method for use thereof
US5904657A (en) * 1997-02-26 1999-05-18 Unsworth; John D. System for guiding devices in body lumens
US20020133222A1 (en) * 1997-03-05 2002-09-19 Das Gladwin S. Expandable stent having a plurality of interconnected expansion modules
US5824053A (en) * 1997-03-18 1998-10-20 Endotex Interventional Systems, Inc. Helical mesh endoprosthesis and methods of use
US5824052A (en) * 1997-03-18 1998-10-20 Endotex Interventional Systems, Inc. Coiled sheet stent having helical articulation and methods of use
US6425915B1 (en) * 1997-03-18 2002-07-30 Endotex Interventional Systems, Inc. Helical mesh endoprosthesis and methods of use
US5824055A (en) * 1997-03-25 1998-10-20 Endotex Interventional Systems, Inc. Stent graft delivery system and methods of use
US20020087046A1 (en) * 1997-04-23 2002-07-04 St. Jude Medical Cardiovascular Group, Inc. Medical grafting methods and apparatus
US6312455B2 (en) 1997-04-25 2001-11-06 Nitinol Devices & Components Stent
GB2324729B (en) 1997-04-30 2002-01-02 Bradford Hospitals Nhs Trust Lung treatment device
US5853004A (en) * 1997-06-02 1998-12-29 Goodman; Evan J. Pharyngeal bulb airway
IL121316A (en) * 1997-07-15 2001-07-24 Litana Ltd Implantable medical device of shape memory alloy
US6248100B1 (en) 1997-08-14 2001-06-19 Scimed Life Systems, Inc. Drainage catheter delivery system
US6203513B1 (en) 1997-11-20 2001-03-20 Optonol Ltd. Flow regulating implant, method of manufacture, and delivery device
US8313454B2 (en) * 1997-11-20 2012-11-20 Optonol Ltd. Fluid drainage device, delivery device, and associated methods of use and manufacture
US6156062A (en) * 1997-12-03 2000-12-05 Ave Connaught Helically wrapped interlocking stent
US6136015A (en) * 1998-08-25 2000-10-24 Micrus Corporation Vasoocclusive coil
US6241691B1 (en) 1997-12-05 2001-06-05 Micrus Corporation Coated superelastic stent
US6159165A (en) 1997-12-05 2000-12-12 Micrus Corporation Three dimensional spherical micro-coils manufactured from radiopaque nickel-titanium microstrand
US6168570B1 (en) 1997-12-05 2001-01-02 Micrus Corporation Micro-strand cable with enhanced radiopacity
ATE320229T1 (en) * 1998-01-30 2006-04-15 St Jude Medical Atg Inc MEDICAL TRANSPLANT CONNECTOR OR PLUG AND METHOD FOR PRODUCING THE SAME
US7713297B2 (en) 1998-04-11 2010-05-11 Boston Scientific Scimed, Inc. Drug-releasing stent with ceramic-containing layer
US6168615B1 (en) 1998-05-04 2001-01-02 Micrus Corporation Method and apparatus for occlusion and reinforcement of aneurysms
US6293960B1 (en) 1998-05-22 2001-09-25 Micrus Corporation Catheter with shape memory polymer distal tip for deployment of therapeutic devices
US6250308B1 (en) 1998-06-16 2001-06-26 Cardiac Concepts, Inc. Mitral valve annuloplasty ring and method of implanting
US5980550A (en) * 1998-06-18 1999-11-09 Target Therapeutics, Inc. Water-soluble coating for bioactive vasoocclusive devices
US6652581B1 (en) * 1998-07-07 2003-11-25 Boston Scientific Scimed, Inc. Medical device with porous surface for controlled drug release and method of making the same
US6656218B1 (en) 1998-07-24 2003-12-02 Micrus Corporation Intravascular flow modifier and reinforcement device
US6165194A (en) 1998-07-24 2000-12-26 Micrus Corporation Intravascular flow modifier and reinforcement device
KR100618932B1 (en) 1998-08-19 2006-09-04 쿡 인코포레이티드 Preformed wire guide
US6149664A (en) * 1998-08-27 2000-11-21 Micrus Corporation Shape memory pusher introducer for vasoocclusive devices
US6478773B1 (en) * 1998-12-21 2002-11-12 Micrus Corporation Apparatus for deployment of micro-coil using a catheter
US6500149B2 (en) 1998-08-31 2002-12-31 Deepak Gandhi Apparatus for deployment of micro-coil using a catheter
US6296622B1 (en) 1998-12-21 2001-10-02 Micrus Corporation Endoluminal device delivery system using axially recovering shape memory material
US6755856B2 (en) 1998-09-05 2004-06-29 Abbott Laboratories Vascular Enterprises Limited Methods and apparatus for stenting comprising enhanced embolic protection, coupled with improved protection against restenosis and thrombus formation
US6682554B2 (en) 1998-09-05 2004-01-27 Jomed Gmbh Methods and apparatus for a stent having an expandable web structure
US7815763B2 (en) * 2001-09-28 2010-10-19 Abbott Laboratories Vascular Enterprises Limited Porous membranes for medical implants and methods of manufacture
US7887578B2 (en) 1998-09-05 2011-02-15 Abbott Laboratories Vascular Enterprises Limited Stent having an expandable web structure
US6547814B2 (en) * 1998-09-30 2003-04-15 Impra, Inc. Selective adherence of stent-graft coverings
ES2386339T3 (en) 1998-09-30 2012-08-17 Bard Peripheral Vascular, Inc. Selective adhesion of graft-stent covers, mandrel and method of making a graft-stent device
US6358276B1 (en) 1998-09-30 2002-03-19 Impra, Inc. Fluid containing endoluminal stent
WO2000021443A1 (en) * 1998-10-09 2000-04-20 Cook Incorporated Vasoocclusion coil device having a core therein
US6019779A (en) * 1998-10-09 2000-02-01 Intratherapeutics Inc. Multi-filar coil medical stent
US6494879B2 (en) 1998-10-15 2002-12-17 Scimed Life Systems, Inc. Treating urinary retention
US6475234B1 (en) * 1998-10-26 2002-11-05 Medinol, Ltd. Balloon expandable covered stents
US6475222B1 (en) * 1998-11-06 2002-11-05 St. Jude Medical Atg, Inc. Minimally invasive revascularization apparatus and methods
US6508252B1 (en) * 1998-11-06 2003-01-21 St. Jude Medical Atg, Inc. Medical grafting methods and apparatus
US6348067B1 (en) * 1998-11-25 2002-02-19 Israel Aircraft Industries Ltd. Method and system with shape memory heating apparatus for temporarily supporting a tubular organ
US6258118B1 (en) 1998-11-25 2001-07-10 Israel Aircraft Industries Ltd. Removable support device
US6413273B1 (en) 1998-11-25 2002-07-02 Israel Aircraft Industries Ltd. Method and system for temporarily supporting a tubular organ
US6102932A (en) 1998-12-15 2000-08-15 Micrus Corporation Intravascular device push wire delivery system
US6383204B1 (en) 1998-12-15 2002-05-07 Micrus Corporation Variable stiffness coil for vasoocclusive devices
US6835185B2 (en) 1998-12-21 2004-12-28 Micrus Corporation Intravascular device deployment mechanism incorporating mechanical detachment
US6165140A (en) 1998-12-28 2000-12-26 Micrus Corporation Composite guidewire
EP1156758B1 (en) 1999-02-26 2008-10-15 LeMaitre Vascular, Inc. Coiled stent
US6248122B1 (en) 1999-02-26 2001-06-19 Vascular Architects, Inc. Catheter with controlled release endoluminal prosthesis
US6332892B1 (en) 1999-03-02 2001-12-25 Scimed Life Systems, Inc. Medical device with one or more helical coils
US6221066B1 (en) 1999-03-09 2001-04-24 Micrus Corporation Shape memory segmented detachable coil
EP1161185A2 (en) 1999-03-09 2001-12-12 St. Jude Medical Cardiovascular Group, Inc. Medical grafting methods and apparatus
US6887235B2 (en) 1999-03-24 2005-05-03 Micrus Corporation Variable stiffness heating catheter
US6352531B1 (en) 1999-03-24 2002-03-05 Micrus Corporation Variable stiffness optical fiber shaft
US6752813B2 (en) 1999-04-09 2004-06-22 Evalve, Inc. Methods and devices for capturing and fixing leaflets in valve repair
US6860899B1 (en) * 1999-04-15 2005-03-01 Boston Scientific Scimed, Inc. Method for treating neurovascular aneurysms
US6080178A (en) * 1999-04-20 2000-06-27 Meglin; Allen J. Vena cava filter
US6436120B1 (en) 1999-04-20 2002-08-20 Allen J. Meglin Vena cava filter
US6319237B1 (en) 1999-04-23 2001-11-20 Icd Labs, Inc. Urinary sphincter control device
US6712836B1 (en) 1999-05-13 2004-03-30 St. Jude Medical Atg, Inc. Apparatus and methods for closing septal defects and occluding blood flow
US6558342B1 (en) 1999-06-02 2003-05-06 Optonol Ltd. Flow control device, introducer and method of implanting
US6699256B1 (en) 1999-06-04 2004-03-02 St. Jude Medical Atg, Inc. Medical grafting apparatus and methods
US6709667B1 (en) 1999-08-23 2004-03-23 Conceptus, Inc. Deployment actuation system for intrafallopian contraception
AU1361901A (en) * 1999-11-03 2001-05-14 Endocare, Inc. Method of loading a stent on a delivery catheter
US7044980B2 (en) * 2000-02-03 2006-05-16 Boston Scientific Scimed, Inc. Facilitating drainage
US7740637B2 (en) 2000-02-09 2010-06-22 Micrus Endovascular Corporation Apparatus and method for deployment of a therapeutic device using a catheter
AU2001289310B2 (en) 2000-04-11 2006-07-06 Boston Scientific Limited Reinforced retention structures
US20050043757A1 (en) * 2000-06-12 2005-02-24 Michael Arad Medical devices formed from shape memory alloys displaying a stress-retained martensitic state and method for use thereof
US6572648B1 (en) * 2000-06-30 2003-06-03 Vascular Architects, Inc. Endoluminal prosthesis and tissue separation condition treatment method
US6974473B2 (en) 2000-06-30 2005-12-13 Vascular Architects, Inc. Function-enhanced thrombolytic AV fistula and method
US6585760B1 (en) 2000-06-30 2003-07-01 Vascular Architects, Inc AV fistula and function enhancing method
US20020077693A1 (en) * 2000-12-19 2002-06-20 Barclay Bruce J. Covered, coiled drug delivery stent and method
JP2002035135A (en) * 2000-07-31 2002-02-05 Manii Kk Stent and method for manufacturing stent
US6799637B2 (en) 2000-10-20 2004-10-05 Schlumberger Technology Corporation Expandable tubing and method
US6509094B1 (en) 2000-11-08 2003-01-21 Tilak M. Shah Polyimide coated shape-memory material and method of making same
US20010044650A1 (en) * 2001-01-12 2001-11-22 Simso Eric J. Stent for in-stent restenosis
NO335594B1 (en) 2001-01-16 2015-01-12 Halliburton Energy Serv Inc Expandable devices and methods thereof
US7556646B2 (en) * 2001-09-13 2009-07-07 Edwards Lifesciences Corporation Methods and apparatuses for deploying minimally-invasive heart valves
US6733525B2 (en) * 2001-03-23 2004-05-11 Edwards Lifesciences Corporation Rolled minimally-invasive heart valves and methods of use
US7374571B2 (en) 2001-03-23 2008-05-20 Edwards Lifesciences Corporation Rolled minimally-invasive heart valves and methods of manufacture
US6719804B2 (en) 2001-04-02 2004-04-13 Scimed Life Systems, Inc. Medical stent and related methods
US6685745B2 (en) 2001-05-15 2004-02-03 Scimed Life Systems, Inc. Delivering an agent to a patient's body
US6494855B2 (en) 2001-05-16 2002-12-17 Scimed Life Systems, Inc. Draining bodily fluid
ITTO20010465A1 (en) * 2001-05-18 2002-11-18 Sorin Biomedica Cardio Spa MODIFYING STRUCTURE ELEMENT FOR INSTALLATION DEVICES, RELATED INSTALLATION DEVICE AND CONSTRUCTION PROCEDURE.
US6981964B2 (en) * 2001-05-22 2006-01-03 Boston Scientific Scimed, Inc. Draining bodily fluids with a stent
US7338514B2 (en) * 2001-06-01 2008-03-04 St. Jude Medical, Cardiology Division, Inc. Closure devices, related delivery methods and tools, and related methods of use
US6666880B1 (en) * 2001-06-19 2003-12-23 Advised Cardiovascular Systems, Inc. Method and system for securing a coated stent to a balloon catheter
US7727221B2 (en) 2001-06-27 2010-06-01 Cardiac Pacemakers Inc. Method and device for electrochemical formation of therapeutic species in vivo
US8252040B2 (en) 2001-07-20 2012-08-28 Microvention, Inc. Aneurysm treatment device and method of use
US6790223B2 (en) 2001-09-21 2004-09-14 Scimed Life Systems, Inc. Delivering a uretheral stent
US6620202B2 (en) 2001-10-16 2003-09-16 Scimed Life Systems, Inc. Medical stent with variable coil and related methods
JP4148671B2 (en) * 2001-11-06 2008-09-10 ソニー株式会社 Display image control processing apparatus, moving image information transmission / reception system, display image control processing method, moving image information transmission / reception method, and computer program
US7219799B2 (en) * 2002-12-31 2007-05-22 Possis Medical, Inc. Packaging system with oxygen sensor
US20040068314A1 (en) * 2002-01-16 2004-04-08 Jones Donald K. Detachable self -expanding aneurysm cover device
US20050178584A1 (en) * 2002-01-22 2005-08-18 Xingwu Wang Coated stent and MR imaging thereof
US8506647B2 (en) 2002-02-14 2013-08-13 Boston Scientific Scimed, Inc. System for maintaining body canal patency
US6989024B2 (en) * 2002-02-28 2006-01-24 Counter Clockwise, Inc. Guidewire loaded stent for delivery through a catheter
JP4575667B2 (en) 2002-03-08 2010-11-04 エーザイ・アール・アンド・ディー・マネジメント株式会社 Macrocyclic compounds useful as pharmaceuticals
US8328877B2 (en) 2002-03-19 2012-12-11 Boston Scientific Scimed, Inc. Stent retention element and related methods
CA2479764C (en) 2002-03-22 2013-07-30 Eisai Co., Ltd. Hemiasterlin derivatives and uses thereof
US7976564B2 (en) 2002-05-06 2011-07-12 St. Jude Medical, Cardiology Division, Inc. PFO closure devices and related methods of use
US6833003B2 (en) * 2002-06-24 2004-12-21 Cordis Neurovascular Expandable stent and delivery system
US20040261912A1 (en) * 2003-06-27 2004-12-30 Wu Ming H. Method for manufacturing superelastic beta titanium articles and the articles derived therefrom
US20040241037A1 (en) * 2002-06-27 2004-12-02 Wu Ming H. Beta titanium compositions and methods of manufacture thereof
US20040168751A1 (en) * 2002-06-27 2004-09-02 Wu Ming H. Beta titanium compositions and methods of manufacture thereof
US20040052676A1 (en) * 2002-06-27 2004-03-18 Wu Ming H. beta titanium compositions and methods of manufacture thereof
US7001422B2 (en) * 2002-09-23 2006-02-21 Cordis Neurovascular, Inc Expandable stent and delivery system
US6733536B1 (en) 2002-10-22 2004-05-11 Scimed Life Systems Male urethral stent device
WO2004058110A2 (en) * 2002-12-24 2004-07-15 Ovion, Inc. Contraceptive device and delivery system
US7846198B2 (en) * 2002-12-24 2010-12-07 Novostent Corporation Vascular prosthesis and methods of use
US20040158314A1 (en) * 2002-12-24 2004-08-12 Novostent Corporation Ribbon-type vascular prosthesis having stress-relieving articulation and methods of use
US20050033410A1 (en) * 2002-12-24 2005-02-10 Novostent Corporation Vascular prothesis having flexible configuration
US20050165469A1 (en) * 2002-12-24 2005-07-28 Michael Hogendijk Vascular prosthesis including torsional stabilizer and methods of use
US7647931B2 (en) * 2002-12-30 2010-01-19 Quiescence Medical, Inc. Stent for maintaining patency of a body region
US7992566B2 (en) 2002-12-30 2011-08-09 Quiescence Medical, Inc. Apparatus and methods for treating sleep apnea
US7381222B2 (en) 2002-12-30 2008-06-03 Quiescence Medical, Inc. Stent for maintaining patency of a body region
US20040160685A1 (en) * 2003-01-27 2004-08-19 Everardo Daniel Faires Quiros Lower rear view mirror (LRVM for short)
US7314485B2 (en) * 2003-02-03 2008-01-01 Cardiac Dimensions, Inc. Mitral valve device using conditioned shape memory alloy
US6929663B2 (en) * 2003-03-26 2005-08-16 Boston Scientific Scimed, Inc. Longitudinally expanding medical device
US7771463B2 (en) * 2003-03-26 2010-08-10 Ton Dai T Twist-down implant delivery technologies
US20040193178A1 (en) 2003-03-26 2004-09-30 Cardiomind, Inc. Multiple joint implant delivery systems for sequentially-controlled implant deployment
ATE467402T1 (en) * 2003-03-26 2010-05-15 Cardiomind Inc IMPLANT DEPOSIT CATHETER WITH ELECTROLYTICALLY DEGRADABLE COMPOUNDS
US20040199246A1 (en) * 2003-04-02 2004-10-07 Scimed Life Systems, Inc. Expandable stent
US20040254627A1 (en) * 2003-04-04 2004-12-16 Thompson Paul J. Stent with end adapted for flaring
US20040267306A1 (en) 2003-04-11 2004-12-30 Velocimed, L.L.C. Closure devices, related delivery methods, and related methods of use
US8372112B2 (en) 2003-04-11 2013-02-12 St. Jude Medical, Cardiology Division, Inc. Closure devices, related delivery methods, and related methods of use
US7651529B2 (en) 2003-05-09 2010-01-26 Boston Scientific Scimed, Inc. Stricture retractor
US10667823B2 (en) 2003-05-19 2020-06-02 Evalve, Inc. Fixation devices, systems and methods for engaging tissue
WO2004112615A2 (en) * 2003-06-16 2004-12-29 Galdonik Jason A Temporary hemostatic plug apparatus and method of use
DE112004001370B8 (en) * 2003-07-25 2010-06-10 Impliant Ltd. Elastomeric nucleus replacement
US20050043786A1 (en) * 2003-08-18 2005-02-24 Medtronic Ave, Inc. Methods and apparatus for treatment of aneurysmal tissue
US7198675B2 (en) 2003-09-30 2007-04-03 Advanced Cardiovascular Systems Stent mandrel fixture and method for selectively coating surfaces of a stent
US20060241682A1 (en) * 2003-12-08 2006-10-26 Kurz Daniel R Intravascular device push wire delivery system
US9713549B2 (en) * 2004-02-02 2017-07-25 Bayer Healthcare Llc Contraceptive with permeable and impermeable components
WO2005074845A1 (en) * 2004-02-02 2005-08-18 Ams Research Corporation Enhancing tissue ingrowth for contraception
US7651521B2 (en) 2004-03-02 2010-01-26 Cardiomind, Inc. Corewire actuated delivery system with fixed distal stent-carrying extension
US20050209671A1 (en) * 2004-03-02 2005-09-22 Cardiomind, Inc. Corewire actuated delivery system with fixed distal stent-carrying extension
US20050209670A1 (en) * 2004-03-02 2005-09-22 Cardiomind, Inc. Stent delivery system with diameter adaptive restraint
EP1582163A1 (en) * 2004-03-31 2005-10-05 Orthofix International B.V. Intramedullary nail comprising an helical element of shape-memory material
EP2559388B8 (en) * 2004-04-28 2014-03-12 Bayer Essure Inc. Endoscopic delivery of medical devices
US20050246008A1 (en) * 2004-04-30 2005-11-03 Novostent Corporation Delivery system for vascular prostheses and methods of use
DE102004025130A1 (en) * 2004-05-18 2005-12-08 Universitätsklinikum Hamburg-Eppendorf Körperschaft des Öffentlichen Rechts Method and device for investigating sludgeal deposits on materials for endoprostheses and endoprosthesis
US8267985B2 (en) * 2005-05-25 2012-09-18 Tyco Healthcare Group Lp System and method for delivering and deploying an occluding device within a vessel
EP2789342A1 (en) 2004-06-17 2014-10-15 Thrasos Innovation, Inc. TDF-related compounds and analogs thereof
US7862531B2 (en) 2004-06-25 2011-01-04 Optonol Ltd. Flow regulating implants
US7648727B2 (en) 2004-08-26 2010-01-19 Advanced Cardiovascular Systems, Inc. Methods for manufacturing a coated stent-balloon assembly
EP1793744B1 (en) 2004-09-22 2008-12-17 Dendron GmbH Medical implant
US8845676B2 (en) 2004-09-22 2014-09-30 Micro Therapeutics Micro-spiral implantation device
US8535345B2 (en) 2004-10-07 2013-09-17 DePuy Synthes Products, LLC Vasoocclusive coil with biplex windings to improve mechanical properties
WO2006044147A2 (en) * 2004-10-14 2006-04-27 Cardiomind, Inc. Small vessel stent designs
US7455688B2 (en) * 2004-11-12 2008-11-25 Con Interventional Systems, Inc. Ostial stent
US20060136035A1 (en) * 2004-12-20 2006-06-22 Vascular Architects, Inc. A Delaware Corporation Coiled endoluminal prosthesis system and delivery catheter
US20060136034A1 (en) * 2004-12-20 2006-06-22 Vascular Architects, Inc. Delivery catheter and method
US20060206140A1 (en) * 2005-02-24 2006-09-14 Samuel Shaolian Adjustable embolic aneurysm coil
US20060212113A1 (en) * 2005-02-24 2006-09-21 Shaolian Samuel M Externally adjustable endovascular graft implant
US8021374B2 (en) * 2005-03-08 2011-09-20 The Trustees Of Stevens Institute Of Technology Method and device for the controlled delivery and placement of securing elements in a body
USRE47376E1 (en) * 2005-04-01 2019-05-07 Nexgen Medical Systems, Incorporated Thrombus removal system and process
JP4945714B2 (en) 2005-05-25 2012-06-06 タイコ ヘルスケア グループ リミテッド パートナーシップ System and method for supplying and deploying an occlusion device in a conduit
US20060276886A1 (en) * 2005-06-07 2006-12-07 Cardiomind, Inc. Ten-thousandths scale metal reinforced stent delivery guide sheath or restraint
US7918227B1 (en) 2005-07-28 2011-04-05 Phythyon Eve K Endotracheal tube
US9101949B2 (en) 2005-08-04 2015-08-11 Eilaz Babaev Ultrasonic atomization and/or seperation system
US7896539B2 (en) 2005-08-16 2011-03-01 Bacoustics, Llc Ultrasound apparatus and methods for mixing liquids and coating stents
US20070043418A1 (en) * 2005-08-19 2007-02-22 Medlogics Device Corporation Hybrid lumen-supporting stents having self-expanding end segments
US20070055339A1 (en) * 2005-08-23 2007-03-08 George William R Staged stent delivery systems
CA2863125A1 (en) 2005-09-20 2007-03-29 Thrasos Innovation, Inc. Tdf-related compounds and analogs thereof
US20070100414A1 (en) 2005-11-02 2007-05-03 Cardiomind, Inc. Indirect-release electrolytic implant delivery systems
WO2007053791A1 (en) * 2005-11-07 2007-05-10 Med Institute, Inc. Stent with orientation-dependent properties
EP1954224B1 (en) * 2005-11-14 2013-05-29 Covidien LP Stent delivery system for ostial locations in a conduit
US7867547B2 (en) 2005-12-19 2011-01-11 Advanced Cardiovascular Systems, Inc. Selectively coating luminal surfaces of stents
US8840660B2 (en) 2006-01-05 2014-09-23 Boston Scientific Scimed, Inc. Bioerodible endoprostheses and methods of making the same
US8089029B2 (en) 2006-02-01 2012-01-03 Boston Scientific Scimed, Inc. Bioabsorbable metal medical device and method of manufacture
WO2007095031A2 (en) * 2006-02-13 2007-08-23 Bay Street Medical, Inc. System for delivering a stent
US7699884B2 (en) 2006-03-22 2010-04-20 Cardiomind, Inc. Method of stenting with minimal diameter guided delivery systems
US20070224235A1 (en) 2006-03-24 2007-09-27 Barron Tenney Medical devices having nanoporous coatings for controlled therapeutic agent delivery
US8187620B2 (en) 2006-03-27 2012-05-29 Boston Scientific Scimed, Inc. Medical devices comprising a porous metal oxide or metal material and a polymer coating for delivering therapeutic agents
US8235047B2 (en) 2006-03-30 2012-08-07 Conceptus, Inc. Methods and devices for deployment into a lumen
US8562628B2 (en) * 2006-04-03 2013-10-22 Conceptus, Inc. Linear motion delivery system for female sterilization device
US8048150B2 (en) 2006-04-12 2011-11-01 Boston Scientific Scimed, Inc. Endoprosthesis having a fiber meshwork disposed thereon
US8777979B2 (en) 2006-04-17 2014-07-15 Covidien Lp System and method for mechanically positioning intravascular implants
KR20090008347A (en) 2006-04-17 2009-01-21 마이크로 테라퓨틱스 인코포레이티드 System and method for mechanically positioning intravascular implants
US8003156B2 (en) 2006-05-04 2011-08-23 Advanced Cardiovascular Systems, Inc. Rotatable support elements for stents
AU2007267695A1 (en) * 2006-05-23 2007-12-06 Entrigue Surgical, Inc. Sinus tube
JP2007319516A (en) * 2006-06-02 2007-12-13 Norikata Taguma Gastrostomy tube using shape memory alloy and its use method
US7914436B1 (en) 2006-06-12 2011-03-29 Abiomed, Inc. Method and apparatus for pumping blood
US8603530B2 (en) 2006-06-14 2013-12-10 Abbott Cardiovascular Systems Inc. Nanoshell therapy
US8048448B2 (en) 2006-06-15 2011-11-01 Abbott Cardiovascular Systems Inc. Nanoshells for drug delivery
US8017237B2 (en) 2006-06-23 2011-09-13 Abbott Cardiovascular Systems, Inc. Nanoshells on polymers
US8815275B2 (en) 2006-06-28 2014-08-26 Boston Scientific Scimed, Inc. Coatings for medical devices comprising a therapeutic agent and a metallic material
WO2008002778A2 (en) 2006-06-29 2008-01-03 Boston Scientific Limited Medical devices with selective coating
EP2037850A2 (en) 2006-07-06 2009-03-25 Quiescence Medical Inc Apparatus and methods for treating sleep apnea
WO2008006097A2 (en) * 2006-07-07 2008-01-10 Intezyne Technologies Llc Covalent modification of metal surfaces
CA2659761A1 (en) 2006-08-02 2008-02-07 Boston Scientific Scimed, Inc. Endoprosthesis with three-dimensional disintegration control
JP2010503469A (en) 2006-09-14 2010-02-04 ボストン サイエンティフィック リミテッド Medical device having drug-eluting film
EP2959925B1 (en) 2006-09-15 2018-08-29 Boston Scientific Limited Medical devices and methods of making the same
ES2368125T3 (en) 2006-09-15 2011-11-14 Boston Scientific Scimed, Inc. BIOEROSIONABLE ENDOPROOTHESIS WITH BIOESTABLE INORGANIC LAYERS.
CA2663271A1 (en) 2006-09-15 2008-03-20 Boston Scientific Limited Bioerodible endoprostheses and methods of making the same
US8808726B2 (en) 2006-09-15 2014-08-19 Boston Scientific Scimed. Inc. Bioerodible endoprostheses and methods of making the same
WO2008036548A2 (en) 2006-09-18 2008-03-27 Boston Scientific Limited Endoprostheses
US7981150B2 (en) 2006-11-09 2011-07-19 Boston Scientific Scimed, Inc. Endoprosthesis with coatings
US8191220B2 (en) * 2006-12-04 2012-06-05 Cook Medical Technologies Llc Method for loading a medical device into a delivery system
WO2008076971A2 (en) * 2006-12-18 2008-06-26 Vacare Technologies, Llc Method and apparatus for transcervical reversible cornual sterilization
EP2277563B1 (en) 2006-12-28 2014-06-25 Boston Scientific Limited Bioerodible endoprostheses and method of making the same
US8070797B2 (en) 2007-03-01 2011-12-06 Boston Scientific Scimed, Inc. Medical device with a porous surface for delivery of a therapeutic agent
US8431149B2 (en) 2007-03-01 2013-04-30 Boston Scientific Scimed, Inc. Coated medical devices for abluminal drug delivery
KR20100015521A (en) 2007-03-13 2010-02-12 마이크로 테라퓨틱스 인코포레이티드 An implant, a mandrel, and a method of forming an implant
US8328860B2 (en) 2007-03-13 2012-12-11 Covidien Lp Implant including a coil and a stretch-resistant member
US20080255654A1 (en) * 2007-03-22 2008-10-16 Bay Street Medical System for delivering a stent
US8067054B2 (en) 2007-04-05 2011-11-29 Boston Scientific Scimed, Inc. Stents with ceramic drug reservoir layer and methods of making and using the same
US7976915B2 (en) 2007-05-23 2011-07-12 Boston Scientific Scimed, Inc. Endoprosthesis with select ceramic morphology
US8128679B2 (en) 2007-05-23 2012-03-06 Abbott Laboratories Vascular Enterprises Limited Flexible stent with torque-absorbing connectors
US8016874B2 (en) 2007-05-23 2011-09-13 Abbott Laboratories Vascular Enterprises Limited Flexible stent with elevated scaffolding properties
US20080300667A1 (en) * 2007-05-31 2008-12-04 Bay Street Medical System for delivering a stent
US8048441B2 (en) 2007-06-25 2011-11-01 Abbott Cardiovascular Systems, Inc. Nanobead releasing medical devices
JP5734650B2 (en) 2007-06-25 2015-06-17 マイクロベンション インコーポレイテッド Self-expanding prosthesis
US7942926B2 (en) 2007-07-11 2011-05-17 Boston Scientific Scimed, Inc. Endoprosthesis coating
US8002823B2 (en) 2007-07-11 2011-08-23 Boston Scientific Scimed, Inc. Endoprosthesis coating
US7780095B2 (en) 2007-07-13 2010-08-24 Bacoustics, Llc Ultrasound pumping apparatus
US7753285B2 (en) 2007-07-13 2010-07-13 Bacoustics, Llc Echoing ultrasound atomization and/or mixing system
US9144508B2 (en) * 2007-07-19 2015-09-29 Back Bay Medical Inc. Radially expandable stent
EP2187988B1 (en) 2007-07-19 2013-08-21 Boston Scientific Limited Endoprosthesis having a non-fouling surface
US7931683B2 (en) 2007-07-27 2011-04-26 Boston Scientific Scimed, Inc. Articles having ceramic coated surfaces
US8815273B2 (en) 2007-07-27 2014-08-26 Boston Scientific Scimed, Inc. Drug eluting medical devices having porous layers
US8221822B2 (en) 2007-07-31 2012-07-17 Boston Scientific Scimed, Inc. Medical device coating by laser cladding
WO2009020520A1 (en) 2007-08-03 2009-02-12 Boston Scientific Scimed, Inc. Coating for medical device having increased surface area
JP5580737B2 (en) * 2007-08-17 2014-08-27 ミクラス エンドバスキュラー エルエルシー Twisted primary wind coil for vascular treatment, method for forming the same, and secondary wind coil
US8052745B2 (en) 2007-09-13 2011-11-08 Boston Scientific Scimed, Inc. Endoprosthesis
US8216632B2 (en) 2007-11-02 2012-07-10 Boston Scientific Scimed, Inc. Endoprosthesis coating
US8029554B2 (en) 2007-11-02 2011-10-04 Boston Scientific Scimed, Inc. Stent with embedded material
US7938855B2 (en) 2007-11-02 2011-05-10 Boston Scientific Scimed, Inc. Deformable underlayer for stent
US8920488B2 (en) 2007-12-20 2014-12-30 Abbott Laboratories Vascular Enterprises Limited Endoprosthesis having a stable architecture
US8337544B2 (en) 2007-12-20 2012-12-25 Abbott Laboratories Vascular Enterprises Limited Endoprosthesis having flexible connectors
US7850726B2 (en) 2007-12-20 2010-12-14 Abbott Laboratories Vascular Enterprises Limited Endoprosthesis having struts linked by foot extensions
US9242070B2 (en) 2007-12-21 2016-01-26 MicronVention, Inc. System and method for locating detachment zone of a detachable implant
WO2009086214A1 (en) 2007-12-21 2009-07-09 Microvention, Inc. A system and method of detecting implant detachment
US8109896B2 (en) 2008-02-11 2012-02-07 Optonol Ltd. Devices and methods for opening fluid passageways
WO2009131911A2 (en) 2008-04-22 2009-10-29 Boston Scientific Scimed, Inc. Medical devices having a coating of inorganic material
ATE547071T1 (en) * 2008-04-23 2012-03-15 Cook Medical Technologies Llc METHOD FOR INSERTING A MEDICAL DEVICE INTO A RELEASE SYSTEM
WO2009132176A2 (en) 2008-04-24 2009-10-29 Boston Scientific Scimed, Inc. Medical devices having inorganic particle layers
US7998192B2 (en) 2008-05-09 2011-08-16 Boston Scientific Scimed, Inc. Endoprostheses
US9675482B2 (en) 2008-05-13 2017-06-13 Covidien Lp Braid implant delivery systems
US8236046B2 (en) 2008-06-10 2012-08-07 Boston Scientific Scimed, Inc. Bioerodible endoprosthesis
EP2303350A2 (en) 2008-06-18 2011-04-06 Boston Scientific Scimed, Inc. Endoprosthesis coating
US7985252B2 (en) 2008-07-30 2011-07-26 Boston Scientific Scimed, Inc. Bioerodible endoprosthesis
EP2326243B1 (en) * 2008-08-22 2017-05-03 Koninklijke Philips N.V. Sensing apparatus for sensing an object
US20100069948A1 (en) * 2008-09-12 2010-03-18 Micrus Endovascular Corporation Self-expandable aneurysm filling device, system and method of placement
US8382824B2 (en) 2008-10-03 2013-02-26 Boston Scientific Scimed, Inc. Medical implant having NANO-crystal grains with barrier layers of metal nitrides or fluorides
US8231980B2 (en) 2008-12-03 2012-07-31 Boston Scientific Scimed, Inc. Medical implants including iridium oxide
US8267992B2 (en) 2009-03-02 2012-09-18 Boston Scientific Scimed, Inc. Self-buffering medical implants
US8071156B2 (en) 2009-03-04 2011-12-06 Boston Scientific Scimed, Inc. Endoprostheses
WO2010121049A1 (en) * 2009-04-15 2010-10-21 Microvention, Inc. Implant delivery system
US8287937B2 (en) 2009-04-24 2012-10-16 Boston Scientific Scimed, Inc. Endoprosthese
US8657870B2 (en) 2009-06-26 2014-02-25 Biosensors International Group, Ltd. Implant delivery apparatus and methods with electrolytic release
US8753303B2 (en) 2009-09-25 2014-06-17 Boston Scientific Scimed, Inc. Delivery system having stent locking structure
US9339631B2 (en) 2009-09-25 2016-05-17 Boston Scientific Scimed, Inc. Locking mechanism for a medical device
US8474120B2 (en) 2009-10-09 2013-07-02 W. L. Gore & Associates, Inc. Bifurcated highly conformable medical device branch access
US9408733B2 (en) * 2009-12-30 2016-08-09 Michael Devon Amos Rotatable connection between a tubular member and an elongate wire of a catheter
TW201125188A (en) * 2010-01-08 2011-07-16 Phoenix Silicon Int Corp Coating removal equipment and its removal method thereof.
US8668732B2 (en) 2010-03-23 2014-03-11 Boston Scientific Scimed, Inc. Surface treated bioerodible metal endoprostheses
WO2011130081A1 (en) 2010-04-14 2011-10-20 Microvention, Inc. Implant delivery device
US8721538B2 (en) 2010-05-10 2014-05-13 St. Louis University Distractor
US9247942B2 (en) 2010-06-29 2016-02-02 Artventive Medical Group, Inc. Reversible tubal contraceptive device
EP2588042A4 (en) 2010-06-29 2015-03-18 Artventive Medical Group Inc Reducing flow through a tubular structure
US9149277B2 (en) 2010-10-18 2015-10-06 Artventive Medical Group, Inc. Expandable device delivery
WO2012058104A1 (en) * 2010-10-28 2012-05-03 Cook Medical Technologies Llc Torsion constrained stent delivery system
JP2014501567A (en) 2010-11-19 2014-01-23 ボストン サイエンティフィック サイムド,インコーポレイテッド Fast exchange stent delivery system
US9265649B2 (en) 2010-12-13 2016-02-23 Quiescence Medical, Inc. Apparatus and methods for treating sleep apnea
US10617514B2 (en) 2010-12-22 2020-04-14 W. L. Gore & Associates, Inc. Biased endoluminal device
US8401643B2 (en) 2011-05-17 2013-03-19 Medtronic Vascular, Inc. Implantable medical sensor and anchoring system
US10849771B2 (en) 2011-06-27 2020-12-01 Boston Scientific Scimed, Inc. Stent delivery systems and methods for making and using stent delivery systems
US9011468B2 (en) 2011-09-13 2015-04-21 Abbott Cardiovascular Systems Inc. Independent gripper
US8945177B2 (en) 2011-09-13 2015-02-03 Abbott Cardiovascular Systems Inc. Gripper pusher mechanism for tissue apposition systems
US9782282B2 (en) 2011-11-14 2017-10-10 W. L. Gore & Associates, Inc. External steerable fiber for use in endoluminal deployment of expandable devices
US9877858B2 (en) 2011-11-14 2018-01-30 W. L. Gore & Associates, Inc. External steerable fiber for use in endoluminal deployment of expandable devices
US9579104B2 (en) 2011-11-30 2017-02-28 Covidien Lp Positioning and detaching implants
US9011480B2 (en) 2012-01-20 2015-04-21 Covidien Lp Aneurysm treatment coils
US20130226278A1 (en) 2012-02-23 2013-08-29 Tyco Healthcare Group Lp Methods and apparatus for luminal stenting
US9072624B2 (en) 2012-02-23 2015-07-07 Covidien Lp Luminal stenting
US9375308B2 (en) 2012-03-13 2016-06-28 W. L. Gore & Associates, Inc. External steerable fiber for use in endoluminal deployment of expandable devices
US9687245B2 (en) 2012-03-23 2017-06-27 Covidien Lp Occlusive devices and methods of use
US9078659B2 (en) 2012-04-23 2015-07-14 Covidien Lp Delivery system with hooks for resheathability
CA2890801C (en) * 2012-05-18 2020-07-14 Biu Biomedical Innovations (Urology) Inc. Modified pusher apparatus
US9155647B2 (en) 2012-07-18 2015-10-13 Covidien Lp Methods and apparatus for luminal stenting
US9724222B2 (en) 2012-07-20 2017-08-08 Covidien Lp Resheathable stent delivery system
FR2996492B1 (en) * 2012-10-05 2014-12-19 Michelin & Cie DEVICE FOR MAKING A TIRE TREAD OF A PNEUMATIC ENVELOPE
US9095344B2 (en) 2013-02-05 2015-08-04 Artventive Medical Group, Inc. Methods and apparatuses for blood vessel occlusion
US8984733B2 (en) 2013-02-05 2015-03-24 Artventive Medical Group, Inc. Bodily lumen occlusion
CA2897860C (en) 2013-03-11 2019-08-20 Teleflex Medical Incorporated Devices with anti-thrombogenic and anti-microbial treatment
JP2014233592A (en) * 2013-06-05 2014-12-15 朝日インテック株式会社 Pusher guide wire
US9737308B2 (en) 2013-06-14 2017-08-22 Artventive Medical Group, Inc. Catheter-assisted tumor treatment
US9636116B2 (en) 2013-06-14 2017-05-02 Artventive Medical Group, Inc. Implantable luminal devices
US9737306B2 (en) 2013-06-14 2017-08-22 Artventive Medical Group, Inc. Implantable luminal devices
US10149968B2 (en) 2013-06-14 2018-12-11 Artventive Medical Group, Inc. Catheter-assisted tumor treatment
US10149965B2 (en) * 2013-07-11 2018-12-11 Cook Medical Technologies Llc Shape memory guide wire
US10130500B2 (en) 2013-07-25 2018-11-20 Covidien Lp Methods and apparatus for luminal stenting
US9782186B2 (en) 2013-08-27 2017-10-10 Covidien Lp Vascular intervention system
US8968383B1 (en) 2013-08-27 2015-03-03 Covidien Lp Delivery of medical devices
US10076399B2 (en) 2013-09-13 2018-09-18 Covidien Lp Endovascular device engagement
US20150201943A1 (en) * 2013-12-30 2015-07-23 BioStruxs, LLC Expandable Device Useful for Anastomosis
US9713475B2 (en) 2014-04-18 2017-07-25 Covidien Lp Embolic medical devices
US10363043B2 (en) 2014-05-01 2019-07-30 Artventive Medical Group, Inc. Treatment of incompetent vessels
US9974638B2 (en) * 2014-06-04 2018-05-22 Boston Scientific Scimed, Inc. Devices and methods for delivery of implants
US9827124B2 (en) * 2014-12-05 2017-11-28 Cook Medical Technologies Llc Magnetic handle assembly for prosthesis delivery device
US10188392B2 (en) 2014-12-19 2019-01-29 Abbott Cardiovascular Systems, Inc. Grasping for tissue repair
US9474596B2 (en) 2015-02-03 2016-10-25 Khalid Sabti Pre-shaped spiral intraocular lens fixation device
US10524912B2 (en) 2015-04-02 2020-01-07 Abbott Cardiovascular Systems, Inc. Tissue fixation devices and methods
US10813644B2 (en) 2016-04-01 2020-10-27 Artventive Medical Group, Inc. Occlusive implant and delivery system
US10376396B2 (en) 2017-01-19 2019-08-13 Covidien Lp Coupling units for medical device delivery systems
US11376112B2 (en) 2017-01-31 2022-07-05 W. L. Gore & Associates, Inc. Pre-strained stent elements
WO2018165358A1 (en) 2017-03-08 2018-09-13 W. L. Gore & Associates, Inc. Steering wire attach for angulation
US10786377B2 (en) 2018-04-12 2020-09-29 Covidien Lp Medical device delivery
US11123209B2 (en) 2018-04-12 2021-09-21 Covidien Lp Medical device delivery
US11413176B2 (en) 2018-04-12 2022-08-16 Covidien Lp Medical device delivery
US11071637B2 (en) 2018-04-12 2021-07-27 Covidien Lp Medical device delivery
JP7309855B2 (en) 2018-08-31 2023-07-18 ダブリュ.エル.ゴア アンド アソシエイツ,インコーポレイティド Pivot delivery system for implantable medical device
WO2020046364A1 (en) 2018-08-31 2020-03-05 W. L. Gore & Associates, Inc. Apparatus, system, and method for steering an implantable medical device
US11534303B2 (en) 2020-04-09 2022-12-27 Evalve, Inc. Devices and systems for accessing and repairing a heart valve
US11413174B2 (en) 2019-06-26 2022-08-16 Covidien Lp Core assembly for medical device delivery systems
JP2022541221A (en) 2019-07-15 2022-09-22 エバルブ,インコーポレイティド Wide clip with non-deforming wings
EP3998993A1 (en) 2019-07-15 2022-05-25 Evalve, Inc. Proximal element actuator fixation and release mechanisms
EP4033970A1 (en) 2019-09-26 2022-08-03 Evalve, Inc. Systems for intra-procedural cardiac pressure monitoring
US11464636B2 (en) 2019-10-11 2022-10-11 Evalve, Inc. Repair clip for variable tissue thickness
WO2021092460A1 (en) 2019-11-08 2021-05-14 Evalve, Inc. Medical device delivery system with locking system
WO2021097124A1 (en) 2019-11-14 2021-05-20 Evalve, Inc. Catheter assembly with coaptation aid and methods for valve repair
WO2021097089A1 (en) 2019-11-14 2021-05-20 Evalve, Inc. Kit with coaptation aid and fixation system and methods for valve repair

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4503569A (en) * 1983-03-03 1985-03-12 Dotter Charles T Transluminally placed expandable graft prosthesis
EP0274846A1 (en) * 1986-12-09 1988-07-20 Boston Scientific Corporation Apparatus for treating hypertrophy of the prostate gland
US4795458A (en) * 1987-07-02 1989-01-03 Regan Barrie F Stent for use following balloon angioplasty
WO1989001351A1 (en) * 1987-08-13 1989-02-23 Terumo Kabushiki Kaisha Catheter
US4913141A (en) * 1988-10-25 1990-04-03 Cordis Corporation Apparatus and method for placement of a stent within a subject vessel
WO1991016005A1 (en) * 1990-04-19 1991-10-31 Stentek Inc. Device for the treatment of constricted vessels
WO1992005747A1 (en) * 1990-10-09 1992-04-16 Moskovsky Institut Stali I Splavov Appliance for implantation in hollow organs and device for its introduction

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3868956A (en) * 1972-06-05 1975-03-04 Ralph J Alfidi Vessel implantable appliance and method of implanting it
US4425908A (en) * 1981-10-22 1984-01-17 Beth Israel Hospital Blood clot filter
US4411655A (en) * 1981-11-30 1983-10-25 Schreck David M Apparatus and method for percutaneous catheterization
US4494531A (en) * 1982-12-06 1985-01-22 Cook, Incorporated Expandable blood clot filter
US4512338A (en) * 1983-01-25 1985-04-23 Balko Alexander B Process for restoring patency to body vessels
US4665906A (en) * 1983-10-14 1987-05-19 Raychem Corporation Medical devices incorporating sim alloy elements
US4733665C2 (en) * 1985-11-07 2002-01-29 Expandable Grafts Partnership Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft
US4878906A (en) * 1986-03-25 1989-11-07 Servetus Partnership Endoprosthesis for repairing a damaged vessel
US4762128A (en) * 1986-12-09 1988-08-09 Advanced Surgical Intervention, Inc. Method and apparatus for treating hypertrophy of the prostate gland
US4800882A (en) * 1987-03-13 1989-01-31 Cook Incorporated Endovascular stent and delivery system
JPS63238872A (en) * 1987-03-25 1988-10-04 テルモ株式会社 Instrument for securing inner diameter of cavity of tubular organ and catheter equipped therewith
US5019085A (en) * 1988-10-25 1991-05-28 Cordis Corporation Apparatus and method for placement of a stent within a subject vessel

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4503569A (en) * 1983-03-03 1985-03-12 Dotter Charles T Transluminally placed expandable graft prosthesis
EP0274846A1 (en) * 1986-12-09 1988-07-20 Boston Scientific Corporation Apparatus for treating hypertrophy of the prostate gland
US4795458A (en) * 1987-07-02 1989-01-03 Regan Barrie F Stent for use following balloon angioplasty
WO1989001351A1 (en) * 1987-08-13 1989-02-23 Terumo Kabushiki Kaisha Catheter
US4913141A (en) * 1988-10-25 1990-04-03 Cordis Corporation Apparatus and method for placement of a stent within a subject vessel
WO1991016005A1 (en) * 1990-04-19 1991-10-31 Stentek Inc. Device for the treatment of constricted vessels
WO1992005747A1 (en) * 1990-10-09 1992-04-16 Moskovsky Institut Stali I Splavov Appliance for implantation in hollow organs and device for its introduction

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2270264B (en) * 1992-09-02 1996-09-25 Ellis Dev Ltd Palliative stent and insertion device
AU689096B2 (en) * 1993-01-27 1998-03-26 Intra Therapeutics, Inc. Vascular and coronary stents
US6514285B1 (en) 1993-03-11 2003-02-04 Medinol Ltd. Stent
US6666881B1 (en) 1993-03-11 2003-12-23 Medinol Ltd. Method of heating a nitinol stent
US6692521B2 (en) 1993-03-11 2004-02-17 Medinol Ltd. Stent
US7033386B2 (en) 1993-03-11 2006-04-25 Medinol Ltd. Stent
US5641373A (en) * 1995-04-17 1997-06-24 Baxter International Inc. Method of manufacturing a radially-enlargeable PTFE tape-reinforced vascular graft
US6863686B2 (en) 1995-04-17 2005-03-08 Donald Shannon Radially expandable tape-reinforced vascular grafts
US8062354B2 (en) 1995-04-17 2011-11-22 Edwards Lifesciences Corporation Radially-expandable PTFE tape-reinforced vascular grafts
WO2003041615A1 (en) * 2001-11-12 2003-05-22 Dendron Gmbh Medical implant

Also Published As

Publication number Publication date
US5147370A (en) 1992-09-15
AU2237792A (en) 1993-01-12
ATE158161T1 (en) 1997-10-15
EP0588959B1 (en) 1997-09-17
DE69222305D1 (en) 1997-10-23
DE69222305T2 (en) 1998-04-16
EP0588959A1 (en) 1994-03-30
WO1992022263A3 (en) 1993-03-04

Similar Documents

Publication Publication Date Title
US5147370A (en) Nitinol stent for hollow body conduits
Maass et al. Radiological follow-up of transluminally inserted vascular endoprostheses: an experimental study using expanding spirals.
US5891190A (en) Endovascular support device and method
US6663661B2 (en) Endovascular support device and method
US5879382A (en) Endovascular support device and method
US6033434A (en) Bifurcated endovascular stent and methods for forming and placing
US7722663B1 (en) Anatomically correct endoluminal prostheses
US6340368B1 (en) Implantable device with radiopaque ends
US6056775A (en) Bifurcated endovascular stents and method and apparatus for their placement
Neuhaus et al. Percutaneous cholangioscopic or transpapillary insertion of self-expanding biliary metal stents
May et al. Memory metal stents for palliation of malignant obstruction of the oesophagus and cardia.
Dohmoto et al. Application of rectal stents for palliation of obstructing rectosigmoid cancer
Stoker et al. Percutaneous metallic self-expandable endoprostheses in malignant hilar biliary obstruction
IL109169A (en) Temporary stent system
JP2012526609A (en) Bioerodible endoprosthesis
US20050004647A1 (en) Hybrid stent apparatus
Parra Treatment of posterior urethral strictures with a titanium urethral stent
Jaschke et al. A new balloon-expandable tantalum stent (Strecker-Stent for the biliary system: Preliminary Experience
RU2460500C1 (en) Device of implant for human and animal vessels
Palascak et al. Treatment of benign ureterointestinal anastomotic strictures with permanent ureteral Wallstent after Camey and Wallace urinary diversion: long-term follow-up
YACHIA Overview: role of stents in urology
Vanderburgh et al. Nonvascular stents
JPH02102669A (en) Stent and its production
PARRA et al. Endoluminal urethral stents: a review
YACHIA Temporary metal stents in bladder outflow obstruction

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU CA HU JP NO RU

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FR GB GR IT LU MC NL SE

AK Designated states

Kind code of ref document: A3

Designated state(s): AU CA HU JP NO RU

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FR GB GR IT LU MC NL SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 1992914225

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1992914225

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: CA

WWG Wipo information: grant in national office

Ref document number: 1992914225

Country of ref document: EP